<!DOCTYPE html>

<html lang="fa">
<meta content="text/html;charset=utf-8" http-equiv="content-type"/>
<head><title>Juvenile idiopathic arthritis: Epidemiology and immunopathogenesis</title><link href="/d/css/bootstrap.min.css" rel="stylesheet"/><link href="/d/css/icofont.min.css" rel="stylesheet"/><link href="/d/css/classy-nav.min.css" rel="stylesheet"/><link href="/d/css/animate.css" rel="stylesheet"/><link href="/d/css/owl.carousel.css" rel="stylesheet"/><link href="/d/css/magnific-popup.css" rel="stylesheet"/><link href="/d/css/owl.theme.default.min.css" rel="stylesheet"/><link href="/d/css/style.css" rel="stylesheet"/><link href="/d/css/rtl_edited.css" rel="stylesheet"/><link href="/d/css/responsive.css" rel="stylesheet"/><link href="https://medilib.ir/uptodate_assets/main.css" rel="stylesheet">
<style>

#myUL {
  list-style-type: none;
  padding: 0;
  margin: 0;
}

#myUL li a {
  border: 1px solid #ddd;
  margin-top: -1px; /* Prevent double borders */
  background-color: #f6f6f6;
  padding: 12px;
  text-decoration: none;
  font-size: 16px;
  color: black;
  display: block
}

#myUL li a:hover:not(.header) {
  background-color: #eee;
}

#searchResult {

  list-style-type: none;
  padding: 0;
  padding-right: 20px;
}

#searchResult li a {
  border: .5px solid #ddd;
  margin-top: -1px; /* Prevent double borders */
  background-color: #79bc21;
  padding: 7px;
  text-decoration: none;
  font-size: 14px;
  color: white;
  display: block
}

#searchResult li a:hover:not(.header) {
  background-color: #222;
}


#txtHint   {
  position: absolute;
  text-shadow: none;
  width: 100%;
  margin-top: -15px;
  padding-right: 10px;

  filter: alpha(opacity=95);
  -moz-opacity: 0.95;
  opacity: 1;
  z-index: 200;
}
.countBubl {
  background:#eb0029;
  color:#fff;
  padding:5px;
  margin-top: 50%;

}
.uptodate-area > div:nth-child(1) > div:nth-child(1) > div:nth-child(1) > span:nth-child(1) > img:nth-child(2) {
 width: 55%;
 padding-left: 20px;
}
.uptodate-area > div:nth-child(1) > div:nth-child(1) > div:nth-child(1) > span:nth-child(1) > img:nth-child(3) {
 width: 20%;
}
 #Uptodate_image {
      width: 50%;
  }#uptodate-area {
      /*z-index: 99;*/
  }
#uptodate-area > div:nth-child(1) > div:nth-child(1) > div:nth-child(1) > div:nth-child(2) {
 margin-left: 10px;
 margin-bottom: 6%;
}
@media (max-width: @screen-xs) {
    .countBubl {
        font-size: 4px ;
    }
    #uptodate_version {
        font-size: 4px ;
    }
}

@media (max-width: @screen-sm) {
    .countBubl {
        font-size: 14px ;
    }
}
@media  all and(max-width: 820) {
    #Uptodate_image {
        width: 80% ;
    }#uptodate-area {
        z-index: 99;
    }
}@media  all and (min-width: 820) and(max-width: 88820){
    #Uptodate_image {
        width: 100% !important;
    }
    .countBubl {
        font-size: 4px ;
    }
}
div.col-md-3:nth-child(3) {
 margin-top: 6%;
}

div.col-md-3:nth-child(3) > img:nth-child(1) {
 width: 100%;
 margin-left: 11px;
}

</style>
<style media="screen" type="text/css">
  .goback {
    width: 200px;
    height: 40px;
    line-height: 40px;
    position: fixed;
    display: none;
    font-size: 15px;
    background: #71c0fa;
    z-index: 1000;
    text-align: center;
    color: #ffffff;
    -webkit-border-radius: 1px;
    -moz-border-radius: 1px;
    border-radius: 50px;
    bottom: 3.8%;
    right: 2%;
}
  .buyPackage {
  width: 100px;
  height: 100px;
  line-height: 40px;
  position: fixed;
  display: none;
  font-size: 10px;
  background: #fa759e;
  z-index: 1000;
  text-align: center;
  color: #ffffff;
  -webkit-border-radius: 1px;
  -moz-border-radius: 1px;
  border-radius: 10px;
  top: 150px;
  right: 2%;
  text-align: center;
}
.uptodate-area {
  /*background-image: url(../../assets/img/news-letter-bg.jpg);*/
  background-position: center center;
  background-size: cover;
  background-repeat: no-repeat;
    background-attachment: fixed;
  position: relative;
}
.uptodate-area::before {
  content: '';
  position: absolute;
  left: 0;
  padding-top: 100px;
  width: 100%;
}
#references{
  display: none;
}
</style>
<style>
section.sticky {
  position: sticky;
  top: 0;
  background-color: #fff !important;
  /*z-index: 100;*/
  /*padding-top: 80px;*/

}
.m4inb{
    border: solid !important;
  }

  .newsletter-area::before {
       background: unset !important;
  }
p {
    color: #555;
}
</style>

<meta content="" name="description"/>
<link href="/d/img/favicon.png" rel="icon" type="image/png"/>
</link></head>
<body>
<!-- Start Main Menu Area -->

<br/>
<br/>
<br/>
<br/>
<div class="container">
<div class="row">
</div>
</div>




<section class="teacher-area ptb-10">
<div class="container">
</div>

<section class="course-details-area ptb-60">
<div class="container">
<div class="uptodate2" style="padding:50px 0px 50px 0px;direction: ltr;text-align: left;">
<h1 style="text-align:center">Juvenile idiopathic arthritis: Epidemiology and immunopathogenesis</h1>
<div class="utdArticleSection utdStyle" id="topicContent"><div id="topicTitle">Juvenile idiopathic arthritis: Epidemiology and immunopathogenesis</div> <div class="authorSectionElem"><div class="authorsElementsLeft"><dl id="topicContributors"><dt><span> </span>Author:</dt><dd><a class="contributor contributor_credentials" rel="noopener noreferrer" target="_blank">Alexei A Grom, MD</a></dd><dt><span> </span>Section Editor:</dt><dd><a class="contributor contributor_credentials" rel="noopener noreferrer" target="_blank">Marisa Klein-Gitelman, MD, MPH</a></dd><dt><span> </span>Deputy Editor:</dt><dd><a class="contributor contributor_credentials" rel="noopener noreferrer" target="_blank">Siobhan M Case, MD, MHS</a></dd></dl></div><div class="authorsElementsRight"><div id="literatureReviewDate"><div class="litReviewSingleLine"><bdi><span class="emphasis">Literature review current through:</span> Jan 2024.</bdi></div><div class="litReviewSingleLine"><bdi><span class="emphasis">This topic last updated:</span> Feb 28, 2022.</bdi></div></div></div></div><div id="topicWhatsNewContainer"></div><div id="topicText"><p class="headingAnchor" id="H1"><span class="h1">INTRODUCTION</span><span class="headingEndMark"> — </span>Juvenile idiopathic arthritis (JIA) is a chronic idiopathic inflammatory disorder primarily involving joints. The epidemiology and immunopathogenesis of JIA are reviewed here. Diagnostic criteria and nomenclature of JIA are presented separately. (See  <a class="medical medical_review" href="/d/html/6412.html" rel="external">"Classification of juvenile idiopathic arthritis"</a>.)</p><p class="headingAnchor" id="H4186997"><span class="h2">Terminology</span><span class="headingEndMark"> — </span>The older terms, "juvenile rheumatoid arthritis" (JRA; used commonly in the United States) and "juvenile chronic arthritis" (JCA; preferred in Europe), have been replaced by the term "juvenile idiopathic arthritis" (JIA). JIA incorporates all of what was called JRA in the past and also includes all other forms of "idiopathic" arthritis in childhood. The term "JRA" will still be used to describe the general patient population in older studies since JRA is a less inclusive term than JIA (the term "JIA" will be used for these older studies if a specific subgroup is specified [eg, systemic JIA]). However, most clinicians assume that the results of these earlier studies of JRA are generally applicable to all the categories included in JIA, although the precise numbers will be somewhat different. The JIA nomenclature should be regarded as a "work in progress" that will be refined as the genetic and pathophysiologic understanding of arthritis improves. All of the discussion of epidemiology and pathogenesis that follows is complicated by the fact that JIA is not a single disease, but several different diseases. While there are elements common to all of these diseases, some forms of JIA, such as the human leukocyte antigen (HLA) B27-associated diseases and systemic JIA, are clearly distinct entities with differing etiologies and pathogenesis.</p><p class="headingAnchor" id="H2"><span class="h1">EPIDEMIOLOGY</span></p><p class="headingAnchor" id="H3"><span class="h2">Overall incidence and prevalence</span><span class="headingEndMark"> — </span>The lack of standard diagnostic criteria has complicated epidemiologic studies. When the revised American College of Rheumatology (ACR; formerly the American Rheumatism Association [ARA]) classification criteria were applied to the Rochester Epidemiology Program Project database, an incidence of 13.9 cases of juvenile rheumatoid arthritis (JRA) per 100,000 per year was reported [<a href="#rid1">1</a>]. A follow-up study utilizing the same database noted a decrease in incidence over a subsequent decade [<a href="#rid2">2</a>].</p><p>The results of other population studies are presented in the table  (<a class="graphic graphic_table graphicRef78901" href="/d/graphic/78901.html" rel="external">table 1</a>) [<a href="#rid3">3-7</a>]. In the Rochester study, the prevalence rate for JRA was 94 patients per 100,000 children on January 1, 1980 and 86 on January 1, 1990 [<a href="#rid2">2</a>]. An extrapolation to the entire United States population under 16 years of age in the year 2000 suggests that there must be 70,000 to 100,000 cases of JRA (active and inactive). However, the population in the Rochester study was predominantly White. The actual prevalence in the total United States population is probably much lower (15,000 to 36,000 in some estimates [<a href="#rid8">8</a>]) because JRA appears to be less common in African American and Asian American populations [<a href="#rid9">9</a>].</p><p>Differences in disease onset among ethnic groups have also been reported [<a href="#rid10">10</a>]. African American children are more likely to have a polyarticular onset than White children, who most often have an oligoarticular onset [<a href="#rid11">11</a>]. Among Japanese children, systemic disease is more common than the oligoarticular form [<a href="#rid12">12</a>]. Genetic factors are likely to contribute to these differences. (See <a class="local">'Pathogenesis'</a> below.)</p><p class="headingAnchor" id="H4"><span class="h2">Age of onset</span><span class="headingEndMark"> — </span>In a series from the United States, the peak incidence of JRA occurred at one to three years of age, with a preponderance of girls in this age group [<a href="#rid13">13</a>]. A second, less prominent peak was noted between ages 8 to 10 years; this peak included more boys with oligoarticular JIA. Other investigators have found a mean age of onset of approximately six years for both systemic and polyarticular disease; oligoarticular disease began at a mean age of approximately 4 years in girls and 10 years in boys [<a href="#rid14">14</a>].</p><p class="headingAnchor" id="H5"><span class="h2">Sex differences</span><span class="headingEndMark"> — </span>In most published series, the female-to-male ratio ranges from 2:1 to 3:1, although equal sex ratios have been described among both Indian and Black South African children [<a href="#rid15">15</a>]. These ratios depend upon the age at onset and the type of disease [<a href="#rid16">16</a>]. As an example, oligoarticular JIA affecting children under eight years old may have a female preponderance as high as 8:1, especially if iridocyclitis is present [<a href="#rid17">17-19</a>]. In contrast, late-onset human leukocyte antigen (HLA) B27-related disease occurs more commonly in males [<a href="#rid20">20,21</a>]. Systemic JIA shows little or no discrimination between sexes.</p><p class="headingAnchor" id="H6"><span class="h2">Secular and seasonal variations</span><span class="headingEndMark"> — </span>Substantial variations in JIA occurrence over extended (secular trends) and shorter (seasonal) periods have been noted in some populations [<a href="#rid2">2,6</a>]. The possibility of an etiologic link was suggested by a report from the United Kingdom in which an influenza virus epidemic occurred prior to an "outbreak" of JIA [<a href="#rid22">22</a>]. The strongest seasonal variations have been observed with systemic JIA [<a href="#rid23">23,24</a>], although this appears to be true only in some geographic regions.</p><p class="headingAnchor" id="H7"><span class="h1">PATHOGENESIS</span><span class="headingEndMark"> — </span>The pathogenesis and etiology of JIA are unclear. As with most autoimmune disorders, interactions among genetic factors, immune mechanisms, and environmental exposures are thought to contribute in most cases. Most of the genetic predisposition to JIA is determined by the major histocompatibility complex (MHC) loci. Multiple MHC loci are associated with the development of JIA, and, in general, these associations are markedly distinct from those seen in adult rheumatoid arthritis (RA). The spectrum of non-human leukocyte antigen (HLA) genes that are associated with JIA is expanding rapidly, but their contribution to the risk of JIA appears to be less significant, and their effects may be shared between JIA and other autoimmune diseases including RA.</p><p class="headingAnchor" id="H8"><span class="h2">Familial predisposition</span><span class="headingEndMark"> — </span>Patterns of inheritance consistent with Mendelian or monogenic inheritance have not been observed in JIA. The level of risk to family members of a proband appears to be only mildly increased [<a href="#rid25">25,26</a>], and families with multiple affected members are uncommon. As examples:</p><p class="bulletIndent1"><span class="glyph">●</span>In the United States, the juvenile rheumatoid arthritis (JRA) Affected Sib Pairs Research Registry in Cincinnati estimated the total number of affected sib pairs at 300 in a population of approximately 250 million [<a href="#rid27">27</a>]. Almost 80 percent of the pairs and 100 percent of twin pairs were concordant for disease type. Among twins, disease onset was separated by a mean of approximately three months. In a subsequent study that included an additional 94 affected pairs, the mean difference in age of onset of non-twin pairs was approximately three years, and concordance of disease type was 73 percent for the two cohorts combined (120 of 164 non-twin affected sib pairs) [<a href="#rid28">28</a>].</p><p></p><p class="bulletIndent1"><span class="glyph">●</span>In Europe, only 12 affected sib pairs were found among over 3000 patients [<a href="#rid29">29</a>].</p><p></p><p>Anecdotal evidence suggests that families with JRA probands have an increased risk of other nonrheumatic autoimmune diseases [<a href="#rid30">30,31</a>].</p><p class="headingAnchor" id="H9"><span class="h2">Predisposing major histocompatibility complex genes</span><span class="headingEndMark"> — </span>Multiple HLA loci are associated with the development of JIA, with specific disease subtypes being linked to specific HLA alleles [<a href="#rid26">26,32</a>]. Genes that do not encode classic HLA proteins but lie within the MHC may also predispose to JIA. (See  <a class="medical medical_review" href="/d/html/3987.html" rel="external">"Human leukocyte antigens (HLA): A roadmap"</a>.)</p><p class="headingAnchor" id="H10"><span class="h3">Early-onset oligoarticular JIA</span><span class="headingEndMark"> — </span>Patients with early-onset oligoarticular JIA, which has a relatively high concordance among siblings [<a href="#rid27">27</a>], constitute the subtype with the most distinctive HLA associations. Correlations with various HLA class II DR and DP alleles include:</p><p class="bulletIndent1"><span class="glyph">●</span>HLA-DR8 [<a href="#rid33">33,34</a>]</p><p class="bulletIndent1"><span class="glyph">●</span>HLA-DR11 [<a href="#rid35">35-37</a>]</p><p class="bulletIndent1"><span class="glyph">●</span>HLA-DR13 [<a href="#rid38">38</a>]</p><p class="bulletIndent1"><span class="glyph">●</span>HLA-DPw2 [<a href="#rid39">39,40</a>]</p><p></p><p>DNA sequence-dependent methodologies have defined more precisely the HLA alleles associated with oligoarticular JIA. Disease susceptibility correlates with particular alleles of each serologically or cellularly defined specificity, such as HLA-DRB1*0801 of DR8 and HLA-DPB1*0201 of DPw2 [<a href="#rid32">32</a>]. Although most associations are with HLA class II, a consistent increase in risk with the HLA class I A2 allele has been reported in females with early-onset oligoarticular JIA [<a href="#rid41">41</a>]. (See  <a class="medical medical_review" href="/d/html/3987.html" rel="external">"Human leukocyte antigens (HLA): A roadmap"</a>.)</p><p>In contrast to these findings, some HLA class II alleles occur with decreased frequency in affected children, suggesting a protective effect. Examples include HLA-DR4 and HLA-DR7 [<a href="#rid32">32</a>].</p><p>Determination of HLA specificities using DNA-based methodologies has also better defined the genetic markers of disease outcome in early-onset oligoarticular JIA. Haplotypes carrying HLA-DRB*0801, HLA-DRB*1301, and HLA-DP*0201 alleles appear to predispose to oligoarticular JIA in general. In contrast, other alleles may contribute to the risk for other clinical manifestations. As examples:</p><p class="bulletIndent1"><span class="glyph">●</span>HLA-DRB1*1104 predisposes to eye disease [<a href="#rid42">42</a>].</p><p></p><p class="bulletIndent1"><span class="glyph">●</span>HLA-DQA1*0101 predisposes to evolution from oligoarticular to polyarticular, erosive disease but is associated with a reduced risk of eye disease [<a href="#rid43">43</a>].</p><p></p><p class="bulletIndent1"><span class="glyph">●</span>HLA-DRB1*0101 has been associated with polyarticular disease [<a href="#rid44">44</a>].</p><p></p><p>Whether the HLA-DQA*0101 or the HLA-DRB*0101 allele is a better marker for the haplotype is uncertain, but there are data that are compatible with either possibility.</p><p>The fact that HLA genes from four loci (HLA-A, HLA-DR, HLA-DQ, and HLA-DP) are involved in inherited predisposition to oligoarticular JIA raises the possibility that these genes make up a potential susceptibility haplotype. However, the absence of linkage disequilibrium between these genes indicates that there are independent genetic effects at three loci. This is illustrated in the table  (<a class="graphic graphic_table graphicRef72340" href="/d/graphic/72340.html" rel="external">table 2</a>), which demonstrates the odds ratio obtained by the cumulative addition of risk factors. Such interactions have been demonstrated in other populations [<a href="#rid45">45</a>].</p><p>In a significant proportion of patients with early-onset oligoarticular JIA, especially those with uveitis, the development of the disease may be associated with the presence of two susceptibility alleles of either the HLA-DR or HLA-DQ loci. Patients who are heterozygous for HLA-DR5/HLA-DR8 have a particularly increased risk for developing eye disease [<a href="#rid46">46</a>]. An HLA-DP gene and the class I HLA-A2 gene also contribute, appearing as independent risk factors. Class II gene homozygosity is not increased in the oligoarticular JIA patient population, suggesting that a dosage effect of any individual gene does not increase risk [<a href="#rid46">46</a>].</p><p class="headingAnchor" id="H11"><span class="h3">Other types</span><span class="headingEndMark"> — </span>HLA associations with clinical forms other than early-onset oligoarticular JIA are less strong. In addition to the previously mentioned increased risk of late-onset oligoarticular JIA associated with HLA-B27 [<a href="#rid20">20,21</a>], the following associations have been reported:</p><p class="bulletIndent1"><span class="glyph">●</span>Polyarticular, rheumatoid factor (RF) negative JIA susceptibility with HLA-DPw3 [<a href="#rid47">47</a>].</p><p></p><p class="bulletIndent1"><span class="glyph">●</span>RF-positive, polyarticular JIA has the same HLA-DR4 associations as does adult RA: HLA-DRB1*0401 and HLA-DRB1*0101 [<a href="#rid48">48</a>]. (See  <a class="medical medical_review" href="/d/html/7487.html" rel="external">"HLA and other susceptibility genes in rheumatoid arthritis"</a>.)</p><p></p><p class="bulletIndent1"><span class="glyph">●</span>Systemic JIA with HLA-DRB1*11 and MHC class II locus variants [<a href="#rid49">49</a>], HLA-DR4 in Northern but not Southern European populations [<a href="#rid32">32</a>], and MHC complex, chromosome 1, and other novel loci [<a href="#rid50">50</a>].</p><p></p><p class="headingAnchor" id="H12"><span class="h3">HLA-DR1/DR4 shared epitope hypothesis</span><span class="headingEndMark"> — </span>RA in adults is associated with the presence of the DNA sequence common to human leukocyte antigen (HLA) DR1 and some HLA-DR4 specificities [<a href="#rid51">51,52</a>]. However, the shared epitope hypothesis as applied to adults is not useful for oligoarticular JIA, in which HLA-DR4 is protective and HLA-DR1 haplotypes predispose to a polyarticular outcome. Similarly, patients with seronegative polyarticular JIA do not carry the appropriate epitopes. The only JIA group in which the shared epitope hypothesis may hold is in older children with polyarticular disease who are immunoglobulin M (IgM) RF positive. These patients have the childhood equivalent of adult RA; they represent fewer than 10 percent of all patients with JIA. (See  <a class="medical medical_review" href="/d/html/7487.html" rel="external">"HLA and other susceptibility genes in rheumatoid arthritis", section on 'Individual alleles and the shared epitope'</a>.)</p><p class="headingAnchor" id="H13"><span class="h3">Age-specific effects</span><span class="headingEndMark"> — </span>There is new evidence that some genes operative in JIA appear to have a "window-of-effect," during which time they may contribute risk of disease but be neutral or even protective at other times [<a href="#rid53">53</a>]. This appears to be particularly true in the oligoarticular groups, in which HLA-related risks clearly differ with age. For example, 50 percent of children carrying at least one of the susceptibility MHC alleles have disease onset prior to their third birthday, suggesting that the period of susceptibility to early-onset oligoarticular JIA is limited to the first years of life. In contrast, HLA-B27 and DR-4 appear to be associated with the protection against early-onset oligoarticular JIA early in life but with the increased risk for other forms of JIA later in childhood  (<a class="graphic graphic_figure graphicRef79342" href="/d/graphic/79342.html" rel="external">figure 1</a>).</p><p class="headingAnchor" id="H14"><span class="h2">Predisposing non-HLA genes</span><span class="headingEndMark"> — </span>Increasing evidence supports the concept that the occurrence of JIA and its phenotype is determined by complex genetic traits with "genetic interplay" between human leukocyte antigen (HLA) and non-HLA predisposing alleles [<a href="#rid54">54</a>]. The spectrum of non-HLA genes that may be associated with JIA is expanding rapidly, as illustrated in the table  (<a class="graphic graphic_figure graphicRef79960" href="/d/graphic/79960.html" rel="external">figure 2</a>) [<a href="#rid18">18,35,55-67</a>]. However, their contribution to the risk of JIA appears to be less significant than that of HLA genes, and their effects may not be specific to JIA. In general, the odds ratios are low, and distinguishing between founder effects (the incomplete mixing of genetically disparate populations) and associations that relate to pathogenesis has been difficult. Reproducible associations with odds ratios greater than two have been noted with interleukin (IL) 6 and macrophage migration inhibitory factor (MIF) promoter polymorphisms [<a href="#rid68">68</a>]. The IL-6 promoter (-174G) allele is significantly associated with systemic disease in children older than the age of five years but not in younger children [<a href="#rid69">69</a>].</p><p>The use of genetic markers, such as microsatellite polymorphisms, suggests the presence of other, as yet unknown genes, which are associated with JIA. As an example, the marker D6S265*5, which is in proximity to, but distinct from, the HLA-A locus, is more commonly found in Norwegian children with seronegative forms of JIA than controls [<a href="#rid70">70</a>].</p><p>Initial genome-wide scanning using polymorphic markers on all the chromosomes in 121 families with a pair of affected children has confirmed the linkage of JIA to the HLA region on chromosome 6 and identified several other sites of interest [<a href="#rid71">71</a>]. Evidence for linkage to sites on chromosome 1, 19, and 20 was noted. When affected children were stratified by the type of disease onset, evidence of linkage was found at different chromosomal locations (eg, early-onset polyarticular and oligoarticular disease with chromosomes 7 and 19, respectively), and, when children carrying the HLA-DR8 allele were selected, strong evidence of linkage to a site on chromosome 2 was noted.</p><p>Additional loci and genes associated with adult RA have also been identified in genome-wide association studies (GWAS) of RA, including IL-2 receptor alpha (<em>IL2RA</em>), protein tyrosine phosphatase nonreceptor-type 2 (<em>PTPN2</em>), <em>PTPN22</em>, signal transducer and activator of transcription 4 (<em>STAT4</em>), angiopoietin 1 (<em>ANGPT1</em>), and component of oligomeric Golgi complex 6 (<em>COG6</em>) [<a href="#rid72">72,73</a>]. The latter study also found associations with loci at 3q13 and 10q21 that may be unique to JIA [<a href="#rid73">73</a>]. Dense mapping of suspected loci in 2816 patients with oligoarticular or polyarticular JIA confirmed associations with the HLA region, <em>PTPN2</em>, <em>PTPN22</em>, <em>STAT4</em>, <em>IL2RA</em>, and <em>COG6 </em>[<a href="#rid74">74</a>]. Additional regions were also identified, including several loci involved in the IL-2 pathway, which is important for T cell activation and overall regulation of the immune system. Some examples include <em>IL2, IL21, </em>IL-2 receptor subunit beta (<em>IL2RB</em>),<em> </em>and SH2B adaptor protein 3 (<em>SH2B3</em>)<em> </em>regions<em>. </em>Additionally, when subtype-specific association testing was performed, one region (interferon regulatory factor 1 [<em>IRF1</em>]<em>) </em>differed between oligo- and polyarticular JIA.<em> </em>This region was strongly associated only with oligoarticular JIA. IRF1 is a transcription factor that binds to a number of genes that contain an interferon (IFN) stimulated response element, and it is therefore an important regulator of the immune response.</p><p>Genetic associations in RF-positive polyarticular JIA are strikingly similar to those in adult RA. Combined with the fact that RF-positive polyarticular JIA typically occurs in older children, this type of JIA may represent early-onset RA [<a href="#rid75">75</a>].</p><p class="headingAnchor" id="H15"><span class="h2">Environmental factors</span><span class="headingEndMark"> — </span>Although at least some genetic component is evident in all clinical forms of JIA, the environmental component appears to be stronger for some forms [<a href="#rid76">76</a>]. Potential environmental influences that may improve or worsen disease include infection, antibiotic use, breastfeeding, maternal smoking, and vitamin D/sun exposure [<a href="#rid77">77</a>].</p><p class="headingAnchor" id="H12949770"><span class="h3">Infection</span><span class="headingEndMark"> — </span>An infectious etiology has been suspected for a long time [<a href="#rid78">78</a>]. However, classical epidemiologic studies have not generally shown clustering of JIA that would imply a definite infectious etiology, although some seasonality in systemic disease has been noted [<a href="#rid23">23,24</a>]. In addition, changes in the incidence of JIA over time may reflect an environmental or infectious rather than a genetic effect [<a href="#rid2">2,6</a>]. Several potential pathogens have been proposed, but none have been definitely shown to be casual. The following are of interest:</p><p class="bulletIndent1"><span class="glyph">●</span>A transient arthritis can develop after rubella virus infection or rubella virus vaccine. In addition, limited data suggest that rubella may play a role in JIA. Mean rubella antibody levels were significantly elevated in young children with JIA in one series but were no different to only mildly elevated in two other studies [<a href="#rid79">79-81</a>]. Rubella virus antigen and rubella virus in lymphoreticular cells have been identified in the synovial fluid in some children with JIA [<a href="#rid79">79,82</a>]. The abrupt nature of a relapse of systemic JIA after primary rubella vaccination in one case report suggests that this event was due to molecular mimicry between rubella and JIA rather than directly due to the infection [<a href="#rid83">83</a>]. However, the majority of these references are more than 20 years old, and the question has not been readdressed with modern techniques. (See  <a class="medical medical_review" href="/d/html/6415.html" rel="external">"Oligoarticular juvenile idiopathic arthritis", section on 'Immunizations'</a>.)</p><p></p><p class="bulletIndent1"><span class="glyph">●</span>An Epstein-Barr virus protein has sequence similarities to HLA-DR8, DR11, and DPw2, all of which are associated with oligoarticular JIA [<a href="#rid84">84</a>]. This and the finding of cross-reactive T cell-mediated cytotoxicity stimulated by HLA and viral-derived peptides suggests a role for molecular mimicry [<a href="#rid85">85</a>].</p><p></p><p class="bulletIndent1"><span class="glyph">●</span><em>Chlamydia</em> has been identified in the joints of some children with arthritis, although the significance of this in the context of JIA is uncertain. The clinical presentation of chlamydial arthritis can be similar to JIA, including the development of iridocyclitis [<a href="#rid86">86</a>].</p><p></p><p class="bulletIndent1"><span class="glyph">●</span>Influenza A infection in pregnancy was associated with the subsequent development of polyarticular JIA in childhood in a study from South Wales [<a href="#rid22">22</a>].</p><p></p><p class="bulletIndent1"><span class="glyph">●</span>An evaluation of long-term trends in Canada found that <em>Mycoplasma pneumoniae</em> infections had incidence peaks that coincided with incidence peaks for JRA [<a href="#rid6">6</a>]. Peaks in JRA incidence over years of observation have been noted in other studies but have not been correlated with specific infectious agents [<a href="#rid2">2</a>].</p><p></p><p class="bulletIndent1"><span class="glyph">●</span>Recovery of parvovirus B19 DNA from synovial fluid or serum was higher in 74 patients with various types of JIA than in children without arthritis (35 versus 7 percent, respectively) [<a href="#rid87">87</a>]. There was little difference in the rates of prior infection with parvovirus B1 as estimated by the prevalence of immunoglobulin G (IgG) antibodies to viral proteins (62 versus 52 percent, respectively).</p><p></p><p class="bulletIndent1"><span class="glyph">●</span>HLA-B27 associated forms of JIA can be triggered by bacterial infections [<a href="#rid88">88</a>], as is the case with HLA-B27-associated disease in adults. An immunodominant epitope of <em>Escherichia coli</em> heat shock proteins (HSPs) is a potential target in HLA-B27-positive JIA [<a href="#rid89">89</a>]. (See  <a class="medical medical_review" href="/d/html/7792.html" rel="external">"Pathogenesis of spondyloarthritis"</a>.)</p><p></p><p class="headingAnchor" id="H12949776"><span class="h3">Antibiotics</span><span class="headingEndMark"> — </span>A few studies have found a link between antibiotic use and the development of JIA. The potential underlying mechanism is unknown, but alteration of the intestinal microbiome with subsequent immune dysregulation is postulated [<a href="#rid90">90</a>]. Alternative explanations of the findings include the possibility that these patients develop more frequent infections due to some intrinsic abnormalities in the immune system that may also predispose them to JIA.</p><p class="bulletIndent1"><span class="glyph">●</span>One study examined antibiotic use in all children born in Finland between 2000 and 2010 and diagnosed with JIA by the end of 2012 (n = 1298) and matched controls (n = 5179) [<a href="#rid91">91</a>]. Purchase of one or more courses of antibiotics from birth to the time of diagnosis was associated with an increased risk of JIA (odds ratio [OR] 1.6, 95% CI 1.3-1.9). The risk increased with the number of prescriptions filled.</p><p></p><p class="bulletIndent1"><span class="glyph">●</span>Previous antibiotic prescriptions were compared in a second case-control study of 152 children newly diagnosed with JIA and 1520 controls in the United Kingdom [<a href="#rid90">90</a>]. This study also found that any use of antibiotics was associated with an increased risk of JIA (OR 2.1, 95% CI 1.2-3.5), and the risk was dose dependent. The timing of first antibiotic exposure did not influence the risk, but the risk was greatest for antibiotic exposures that occurred within one year of diagnosis. No appreciable change in risk was seen after adjusting for specific types or numbers of infections. In secondary analyses, having multiple antibiotic-treated upper respiratory tract infections (URIs) was associated with an increased risk of JIA, but having untreated URIs was not. No differences in risk were seen when specific antibiotic types and functions were evaluated. Antiviral and antifungal antimicrobial drugs were not associated with an increased risk of JIA.</p><p></p><p class="headingAnchor" id="H16"><span class="h1">PATHOBIOLOGY</span><span class="headingEndMark"> — </span>The major clinical manifestation of JIA is persistent joint swelling that results from the combination of synovial fluid accumulation and synovial thickening. Such swelling may cause deformities of affected joints due to stretching of periarticular ligaments and tendons. In addition, enzymes released by inflammatory cells within the synovium or synovial fluid may result in degradation of the collagen and proteoglycan matrix of the articular cartilage. Activation of osteoclasts resulting from the production of cytokines by cells within the mass of inflammatory tissue is probably the final pathway of juxta-articular bone demineralization and bone erosions.</p><p>While some mechanisms of disease are likely shared by children with JIA and adults with rheumatoid arthritis (RA), there may be some that are unique to childhood disease. The pathobiology of RA in adults is discussed separately. (See  <a class="medical medical_review" href="/d/html/7513.html" rel="external">"Pathogenesis of rheumatoid arthritis"</a> and  <a class="medical medical_review" href="/d/html/7500.html" rel="external">"Synovial pathology in rheumatoid arthritis"</a>.)</p><p class="headingAnchor" id="H17"><span class="h2">Synovial fluid</span><span class="headingEndMark"> — </span>Synovial fluid in affected joints is increased in amount and decreased in viscosity. Various inflammatory cells are found in the fluid, including neutrophils, plasma cells, dendritic cells, and T cells expressing markers of activation [<a href="#rid92">92</a>]. Mediators of inflammation such as cytokines and cleavage products of the complement system are also abundant [<a href="#rid93">93</a>].</p><p class="headingAnchor" id="H18"><span class="h2">Synovial tissue</span><span class="headingEndMark"> — </span>One of the hallmarks of the pathology of both JIA and RA is the tumor-like expansion of inflamed synovial tissue, or pannus, which causes much of the joint damage [<a href="#rid94">94,95</a>]. As the disease progresses, pannus spreads over the synovial space and adheres to intra-articular cartilage. It is in the areas of pannus-cartilage junction where the cartilage eventually degrades.</p><p>Pannus results from the proliferation of synoviocytes and invasion of the synovial tissue by inflammatory cells recruited from the peripheral circulation. Mitotic figures are rarely seen in synovial histopathology, suggesting that ongoing recruitment of inflammatory cells from peripheral circulation is a major pathway of pannus expansion [<a href="#rid96">96</a>]. Pannus growth is also supported by extensive formation of new blood vessels that provide both a source of nutrients for growing pannus and access for inflammatory cells to infiltrate the synovium.</p><p>The increased angiogenic activity appears to be mediated by growth factors derived from monocytic cells recruited to the synovium in patients with JIA [<a href="#rid97">97-99</a>]. These factors include vascular endothelial growth factors (VEGF), angiopoietin 1 (Ang 1), and osteopontin. In one study, expression of VEGF and Ang and their receptors correlated with the inflammatory activity in the tissues [<a href="#rid97">97</a>]. Another study showed a strong correlation between increased serum levels of VEGF and disease activity in polyarticular JIA [<a href="#rid98">98</a>].</p><p class="headingAnchor" id="H19"><span class="h2">Cellular infiltrate</span><span class="headingEndMark"> — </span>Light and electron microscopic studies of the synovium in JIA reveal prominent infiltration with lymphocytes, plasma cells, and macrophages as well as proliferation of fibroblast- and macrophage-like synoviocytes. Infiltration with inflammatory cells is inhomogeneous: lightly infiltrated areas alternate with areas of dense cell aggregates [<a href="#rid94">94</a>].</p><p>Inflammatory cell aggregates are usually seen around or near blood vessels and are comprised of clusters of CD4-positive cells surrounded by a mantle of mixed CD4- and CD8-positive cells and B cells. In one small series of newly diagnosed, untreated patients, those with polyarthritis had significantly higher numbers of CD4- and CD8-positive T cells and B cells than patients with oligoarthritis [<a href="#rid100">100</a>]. Patients with persistent oligoarthritis had fewer CD3- and CD4-positive T cells and B cells than those who went on to develop extended oligoarthritis. CD68-positive cells of monocyte/macrophage lineage are numerous and are typically found in the cell aggregates. This pattern of findings resembles that of classic delayed-type hypersensitivity reactions [<a href="#rid101">101</a>]. In general, tissues from patients with the polyarticular form of JIA appear to have somewhat larger mononuclear cell foci as compared with oligoarticular JIA patients. However, the tissues cannot be reliably distinguished solely on this basis [<a href="#rid102">102</a>]. The meaning of these findings in relation to disease pathogenesis remains unclear.</p><p>Dendritic cells appear in increased numbers within the synovial membrane and fluid. Dendritic cells from the synovial compartment are larger than most of those from peripheral blood and have a more extensive Golgi complex [<a href="#rid94">94</a>]. They are often found near T cells [<a href="#rid103">103</a>]. A distinctive feature of such synovial dendritic cells is their high level of human leukocyte antigen (HLA) DQ and DR expression.</p><p>Dendritic cells are particularly potent antigen-presenting cells [<a href="#rid104">104</a>]. Since their main function is to present antigens, it is reasonable to believe that antigen presentation is taking place in inflamed synovium. This notion is supported by the demonstration that dendritic cells from joints of some patients with JIA stimulate autologous lymphocytes in a mixed lymphocyte reaction [<a href="#rid105">105</a>].</p><p>Most of the T cells infiltrating synovium are of a memory phenotype. T cell activation levels vary among different areas in synovium. Most interleukin (IL) 2 receptor-positive cells are found in the "mantle" surrounding the inflammatory cell aggregates or in interaggregate areas [<a href="#rid9">9</a>]. DNA-synthesizing T cell blasts represent no more than 5 percent of all synovial compartment mononuclear cells [<a href="#rid11">11</a>], suggesting that most of these cells are recruited from the peripheral circulation. Among the small proportion of radiolabeled blast cells, CD4+ lymphocytes are the dominant cell population [<a href="#rid106">106</a>].</p><p class="headingAnchor" id="H20"><span class="h2">Recruitment of cells into synovium</span><span class="headingEndMark"> — </span>Infiltration into the synovium depends upon an interplay of vascular factors, cytokines, adhesion molecules, and chemokines.</p><p class="headingAnchor" id="H21"><span class="h3">Vascular factors</span><span class="headingEndMark"> — </span>Mononuclear cell aggregates are found predominantly around blood vessels, particularly postcapillary venules that have distinct morphology [<a href="#rid94">94</a>]. These venules are lined by tall, metabolically active endothelial cells that express high levels of adhesion molecules, features similar to those observed in venules of lymphoid organs. Some of the postcapillary venules in lymphoid organs are specialized to facilitate the transendothelial migration of circulating lymphocytes [<a href="#rid96">96,107</a>]. These specialized high endothelial venules (HEV) may play a similar role in JIA synovium. As an example, CD4+, HLA-DR+ lymphocytes from peripheral blood of children with JIA adhere to human umbilical vein endothelial cells that have been activated by tumor necrosis factor (TNF) alpha [<a href="#rid108">108</a>].</p><p class="headingAnchor" id="H22"><span class="h3">Cytokines promoting immune cell recruitment into synovium</span><span class="headingEndMark"> — </span>Given the abundance of TNF-alpha in juvenile rheumatoid arthritis (JRA) synovial tissues and the high levels of the p55 TNF receptor on the synovial endothelial cells [<a href="#rid109">109</a>], it is likely that TNF-alpha plays a pivotal role in the enhancement of inflammatory cell trafficking into inflamed synovium. IL-15 is another cytokine that enhances the transendothelial migration of lymphocytes to RA synovium [<a href="#rid110">110</a>]. IL-15 appears to be one of the most highly expressed cytokines in JRA synovium [<a href="#rid111">111</a>].</p><p>Macrophage migration inhibitory factor (MIF) may also play a role in JIA. Both serum and synovial fluid levels of this cytokine may be elevated in children with systemic disease [<a href="#rid112">112</a>]. Other evidence for a contribution of MIF in this subset is the correlation between increased disease severity, as estimated from swollen joint counts and duration of corticosteroid therapy, and the presence of a single nucleotide polymorphism in the promoter (noncoding) region of the <em>MIF</em> gene [<a href="#rid113">113,114</a>].</p><p class="headingAnchor" id="H23"><span class="h3">Adhesion molecules</span><span class="headingEndMark"> — </span>Trafficking into synovium may also be enhanced by overexpression on lymphocytes of very late activation antigen (VLA-1), a surface protein from the integrin family of adhesion molecules that mediates leukocyte adhesion to matrix proteins [<a href="#rid115">115</a>]. The recruitment of proinflammatory cells into synovium does not appear to be random. Selection of predominantly T helper cell type 1 (Th1) lymphocytes may be dependent upon various chemokines and be both antigen specific and antigen nonspecific [<a href="#rid116">116,117</a>].</p><p class="headingAnchor" id="H24"><span class="h2">T cell contribution</span><span class="headingEndMark"> — </span>T cell receptor (TCR) alpha-beta-T cells are the predominant cell population in the JIA synovium and exhibit phenotypic and functional characteristics of cells that have undergone prior activation in vivo. These characteristics include expression of IL-2 receptors (CD25) [<a href="#rid118">118</a>], early activation antigen CD69, CD45RO (memory phenotype), VLA-1 [<a href="#rid115">115</a>], and HLA class II antigens [<a href="#rid92">92,119</a>]. These activated effector T cells have impaired sensitivity to immunoregulation by regulatory T cells (CD4+CD25+FoxP3+ Tregs) in synovial fluid [<a href="#rid120">120</a>]. (See  <a class="medical medical_review" href="/d/html/13933.html" rel="external">"Normal B and T lymphocyte development"</a>.)</p><p>A theory that such activation might be induced by an autoantigen located in the inflamed joints prompted a search for clonally expanded synovial T cell populations, an approach that had been successfully utilized in experimental allergic encephalomyelitis [<a href="#rid121">121</a>]. In this model, a known autoantigen (eg, myelin basic protein) stimulates expansion of T cells with receptor specificity for this particular antigen. Furthermore, clonally expanded T cells utilize a limited number of V-beta segments in their TCRs. It was anticipated that, if detected in the JIA synovium, such populations might provide a clue to the identification of the antigens driving the immune response in JIA.</p><p>Clonal expansion of alpha-beta-T cells in both CD4+ and CD8+ populations can be detected in the synovium of the vast majority of JRA patients [<a href="#rid122">122-125</a>]. Identical clones with the same receptor specificity are present in multiple joints of the same individual and persist over a long period of time [<a href="#rid123">123,125</a>]. Some clones can be detected in peripheral blood as well, although there is preferential accumulation of these clonally expanded populations in inflamed synovial tissues [<a href="#rid123">123,124</a>].</p><p>These findings were thought to be consistent with the concept of persistent antigenic stimulation of T cells in the synovial compartment of JIA patients. However, the discovery of similar clonally expanded CD8+ populations in peripheral blood of healthy adults (usually older than 35 years of age) [<a href="#rid126">126</a>] made some investigators question this concept.</p><p>Further studies were focused on the analysis of the TCR complementarity determining region 3 (CDR3), the site of specific interaction of the TCR with unique peptide-HLA complexes. It was anticipated that expansion of structurally identical clones would be indicative of an ongoing antigen-driven immune response in the joint. Since the CDR3 region is encoded by the variable diversity joining (V-D-J) segments, several studies were carried out to determine whether oligoclonal T cell populations preferentially utilized particular V-alpha or V-beta chain TCR segments. Initially, fewer V-beta families were found in fresh T cells from the synovial fluid than from the peripheral blood [<a href="#rid122">122</a>]. These differences were more obvious when IL-2 receptor-positive T cells were isolated [<a href="#rid122">122</a>]. Restricted usage of V-alpha segments by synovial fluid T cells was also seen. (See  <a class="medical medical_review" href="/d/html/3950.html" rel="external">"T-B-NK+ SCID: Pathogenesis, clinical manifestations, and diagnosis", section on 'T cell receptor generation'</a>.)</p><p>A more comprehensive study of synovial fluid samples obtained from 36 patients with different forms of JRA revealed that the vast majority of JRA patients had multiple synovial T cell clones utilizing a wide variety of different TCR V-beta segments [<a href="#rid124">124</a>]. However, some differences in patterns of TCR V-beta utilization between clinical subtypes of JRA were noted, suggesting that different antigens might be involved in different clinical forms of JRA.</p><p>Subsequently, extensive DNA sequencing efforts showed that, despite the wide diversity of CDR3 motifs, certain similarities between multiple synovial T cell clones derived from an individual patient could be found [<a href="#rid127">127</a>]. These data provided indirect support for the concept that the persistent synovial inflammation in JIA is antigen driven. However, the wide variety of both V-alpha and V-beta segments and CDR3 motifs utilized by clonally expanded T cell populations precludes their use as potential targets for specific immunotherapy.</p><p class="headingAnchor" id="H25"><span class="h3">Gamma-delta-T cells</span><span class="headingEndMark"> — </span>A clonal analysis of JRA synovial T cells responding to IL-2 revealed the presence of a distinct T cell population with a CD3+ CD4-, CD8- phenotype [<a href="#rid118">118</a>]. These cells have gamma-delta (instead of alpha-beta) TCRs and comprise approximately 5 to 10 percent of T cells infiltrating the JRA synovial membrane [<a href="#rid128">128-130</a>]. In most cases, gamma-delta T cells are clustered in lymphoid follicle-like structures [<a href="#rid130">130</a>]. In approximately 30 percent of patients with JRA, the proportions of gamma-delta T cells were increased in synovial fluid relative to peripheral blood [<a href="#rid131">131</a>]. A high proportion of synovial gamma-delta T cells express CD25, CD69, and HLA-DR [<a href="#rid129">129</a>].</p><p>Although the specificity and function of human gamma-delta T cells are unknown, at least some of these cells, including those in JRA synovial fluid, appear to respond to mycobacterial antigens and stress proteins (in particular heat shock protein 65 [hsp65]) [<a href="#rid89">89,132,133</a>]. Heat shock proteins (HSPs) are constitutively expressed in practically all organisms, and increased synthesis can be induced by a variety of stress conditions including inflammation. Utilizing monoclonal antibodies that recognize human hsp60, high levels of expression were demonstrated within synovial lining cells in JRA synovial tissue [<a href="#rid134">134</a>].</p><p class="headingAnchor" id="H6118351"><span class="h3">Heat shock protein-related T cells</span><span class="headingEndMark"> — </span>There is a high degree of homology between bacterial and mammalian Hep2-derived HSPs. During infection, the synthesis of HSP is elevated in both the microorganism and host cells. If crossreactivity occurs between these, it can be inferred that the immune response to HSP would be potentially autoreactive [<a href="#rid135">135</a>]. On the other hand, HSP have been shown to stimulate local expansion of T cells secreting antiinflammatory cytokines such as IL-4 or IL-10 [<a href="#rid136">136,137</a>]. These T cells appear to have a phenotype of so-called immunoregulatory T cells that appear to provide protection against autoimmunity [<a href="#rid138">138</a>]. Indeed, an inverse relationship may hold between high immune responses to human hsp60 and the severity of arthritis in patients with JIA [<a href="#rid137">137,139</a>].</p><p>This is illustrated by the following studies [<a href="#rid140">140,141</a>]:</p><p class="bulletIndent1"><span class="glyph">●</span>In the first study, 13 of15 patients with oligoarticular JIA had peripheral blood T cells that demonstrated reactivity to HSP 60 [<a href="#rid140">140</a>]. Only 1 of 20 patients with polyarticular JIA had a similar finding. HSP reactivity was associated with disease remission by 12 weeks.</p><p></p><p class="bulletIndent1"><span class="glyph">●</span>In contrast, a study of 57 patients with oligoarticular or polyarticular JIA demonstrated an enhanced proliferative response of peripheral blood T cells when exposed to five of eight selected HSP epitopes. This response was absent in both of the control groups (healthy children and children with type 1 diabetes). The relative response of T regulatory and T helper cells was also measured by comparing cytokine production of IL-10 (immunosuppressive cytokine) to interferon (IFN) gamma (proinflammatory cytokine). Only patients with active oligoarticular JIA produced increased levels of IL-10 compared with IFN-gamma. These results suggest that, in patients with active oligoarticular JIA, there is a greater response in the T regulatory cells than in T helper cells.</p><p></p><p>One interpretation of these data is that upregulation of the T regulatory cells in patients with oligoarticular JIA decreases inflammation, leading to less severe disease in these patients compared with those with polyarticular JIA [<a href="#rid141">141,142</a>]. The data also suggest that increased T regulatory cell activity might contribute to better clinical outcomes with early remission of disease [<a href="#rid140">140,142</a>].</p><p class="headingAnchor" id="H26"><span class="h3">T cell-derived cytokines</span><span class="headingEndMark"> — </span>In adults with RA, T cell-derived cytokines are usually undetectable despite heavy T cell infiltration of the synovium. In contrast, T cells in JIA appear to be more actively producing cytokines [<a href="#rid102">102</a>].</p><p>Th1 cytokines such as IFN-gamma or TNF-beta are found in most of the synovial tissue and fluid samples of children with JRA [<a href="#rid93">93,143</a>]. Increased TNF-beta expression correlates with the occurrence of lymphocytic aggregates [<a href="#rid109">109</a>]. The in vitro production of cytokines by T cell clones derived from synovial fluids of oligoarticular JIA were of Th1/Th0 type in one report [<a href="#rid144">144</a>]. Thus, a Th1 cytokine response may be disease promoting. Consistent with this notion, one study showed that higher levels of IFN-gamma and a strong IFN-induced transcriptional signature in synovial fluid mononuclear cells were predictive of progression from oligoarticular to polyarticular disease [<a href="#rid145">145</a>].</p><p>In a subsequent study, synovial fluid CD4+ T cells displayed an overall Th1 phenotype, although scRNA-Seq uncovered heterogeneous effector and regulatory subpopulations, including IFN-induced regulatory T (Treg) cells, peripheral helper T cells, and cytotoxic CD4+ T cells [<a href="#rid146">146</a>].</p><p>Th2 cytokines, such as IL-4 and IL-10, may be produced as well. IL-4 has mainly been demonstrated in tissue and fluid samples obtained from patients with more restricted disease, particularly oligoarticular JIA [<a href="#rid143">143</a>]. IL-10 is more consistently found in JRA tissues [<a href="#rid143">143</a>]. Preliminary evidence suggests that at least some of these cytokines are derived from the immunoregulatory T cells [<a href="#rid138">138,147</a>], which are found in the CD25+ T cell population in both peripheral blood and synovial compartments.</p><p>T cells infiltrating the inflamed synovium in children with JIA may have a skewed cytokine phenotype, which may be due to selective recruitment of cells expressing chemokine receptors characteristic of Th1 cells. This hypothesis is supported by the demonstration of enrichment of synovial fluid lymphocytes for T cells expressing chemokine receptors cysteine-cysteine chemokine receptor (CCR) 5 and cysteine-X-cysteine motif chemokine receptor (CXCR) 3, which are markers for the Th1 phenotype [<a href="#rid148">148,149</a>]. Enrichment of synovial fluid CCR4-bearing T cells, when compared with similar cells in peripheral blood, has also been noted [<a href="#rid150">150</a>].</p><p>JIA synovial tissues are also enriched by chemokines capable of stimulating CCR5 and CXCR3 receptors (eg, interferon inducible protein 10 [IP-10] and RANTES) [<a href="#rid151">151</a>]. I-309 (or CCL1) is also abundant.</p><p>Results from one study suggest that the highly proinflammatory Th17 cells also contribute to joint pathology in JIA [<a href="#rid152">152</a>]. IL-17+ T cells were increased in the joints of children with JIA compared with levels in the blood of JIA patients and controls and were also demonstrated in synovial tissue. IL-17+ T cell numbers were higher in patients with extended oligoarthritis compared with patients with persistent oligoarthritis. Within the joint, there was an inverse relationship between IL-17+ T cells and forkhead box P3-positive (FoxP3+) Treg cells. A higher proportion of Th17 cells is also seen in the peripheral blood of patients with systemic JIA compared with normal controls [<a href="#rid153">153</a>].</p><p class="headingAnchor" id="H27"><span class="h2">Natural killer cells</span><span class="headingEndMark"> — </span>Natural killer (NK) cells in JIA have been assessed in several studies with somewhat contradictory results. No significant differences in the distribution of cells bearing CD16+, a surface marker for cytotoxic T lymphocytes was noted in one report [<a href="#rid115">115</a>]. However, decreased NK cell numbers and an inverse correlation between disease activity and NK cell content has been described by others [<a href="#rid154">154</a>]. Profoundly decreased NK cytolytic activity often associated with abnormal levels of perforin expression may be a distinguishing feature of the systemic form of JIA that puts these patients at risk for the development of macrophage activation syndrome (MAS) [<a href="#rid155">155</a>]. (See <a class="local">'Macrophage activation syndrome'</a> below.)</p><p class="headingAnchor" id="H28"><span class="h2">Macrophages/fibroblasts</span><span class="headingEndMark"> — </span>Increased numbers of macrophages, dendritic cells, and synoviocytes of both fibroblast-like and macrophage-like phenotype are typical features of JIA synovium [<a href="#rid94">94</a>]. The abundance of cytokines secreted by these cells (such as IL-1, IL-6, IL-12, and TNF-alpha) provides further evidence for a major role in perpetuation of the synovial inflammation.</p><p>Evidence of the importance of inflammatory mediators released from such cells includes the following:</p><p class="bulletIndent1"><span class="glyph">●</span>High spontaneous production of IL-1 by mononuclear cells derived from peripheral blood of JRA patients and abundance of IL-1 producing macrophages in inflamed JRA synovium [<a href="#rid156">156</a>].</p><p></p><p class="bulletIndent1"><span class="glyph">●</span>A correlation between levels of IL-6 expression in the serum, the extent of joint involvement, and degree of thrombocytosis in systemic JIA [<a href="#rid157">157</a>].</p><p></p><p class="bulletIndent1"><span class="glyph">●</span>Serum from patients with systemic JIA induced the transcription of IL-1 in healthy peripheral blood mononuclear cells [<a href="#rid158">158</a>].</p><p></p><p class="bulletIndent1"><span class="glyph">●</span>Elevation of IL-12 in the serum and TNF-alpha, TNF-beta, and IL-6 in synovial fluids of a large proportion of JRA patients [<a href="#rid93">93,109</a>].</p><p></p><p class="bulletIndent1"><span class="glyph">●</span>Increased circulating levels of IL-18 in children with systemic disease were not seen in other JIA subtypes or Kawasaki disease [<a href="#rid159">159</a>].</p><p></p><p class="headingAnchor" id="H29"><span class="h3">Role of tumor necrosis factor alpha</span><span class="headingEndMark"> — </span>In the majority of JRA synovial tissue samples, cells staining for TNF-alpha are found within dense cellular aggregates and in the "mantle" of cells surrounding the aggregates [<a href="#rid109">109</a>]. The pattern of distribution of TNF-alpha staining is similar in nature to the pattern observed with CD68 staining. The level of expression of TNF-alpha correlates closely with the degree of inflammatory infiltration of synovia.</p><p>High levels of TNF expression are associated with wide distribution of TNF receptors in the vast majority of tissues. As an example, staining with antibodies specific for the p55 and p75 TNF receptors revealed that cells with diverse morphology expressed TNF receptors on their surfaces. Higher numbers of positive cells were observed in the areas of cellular aggregates adjacent to synovial venules, with the most intense staining seen on the endothelial cells lining the synovial blood vessels [<a href="#rid109">109</a>]. Serum levels of the soluble forms of both the p55 and p75 TNF receptors are elevated in the majority of children with active systemic JIA but only in minority of those with polyarticular or oligoarticular disease [<a href="#rid160">160</a>].</p><p>Activated lymphocytes from peripheral blood of children with JRA adhere to vascular endothelial cells stimulated with TNF-alpha in vitro [<a href="#rid108">108</a>]. In vivo, this would be expected to lead to the extravasation of such cells and their accumulation at the site of inflammation. These observations suggest that one of the mechanisms by which TNF-alpha amplifies inflammation in JIA is its ability to promote trafficking of the inflammatory cells from peripheral circulation into synovium.</p><p>The proinflammatory role of TNF-alpha in rheumatoid disease does not appear to be limited to only synovium. TNF-alpha is a major proinflammatory cytokine with both local and systemic effects [<a href="#rid161">161</a>]:</p><p class="bulletIndent1"><span class="glyph">●</span>At low concentrations, it acts locally, mostly as a paracrine and autocrine regulator of leukocytes and vascular endothelial cells. These actions contribute to the accumulation of inflammatory cells at local site of inflammation.</p><p></p><p class="bulletIndent1"><span class="glyph">●</span>When production of TNF-alpha is increased significantly, it is released into peripheral circulation causing a number of systemic effects. As an example, TNF-alpha acts on hypothalamic regulatory systems to induce fever and stimulate hepatocytes to produce proteins that constitute the acute phase response. (See  <a class="medical medical_review" href="/d/html/7483.html" rel="external">"Acute phase reactants"</a>.)</p><p></p><p class="bulletIndent1"><span class="glyph">●</span>When TNF-alpha is produced at high levels over a long period of time, it also suppresses the bone marrow and may cause metabolic alterations leading to cachexia.</p><p></p><p>Although similar symptoms and signs are often observed in JIA, particularly in the systemic form, it is not clear to which extent they can be attributed to TNF-alpha. The beneficial clinical experience with anti-TNF-alpha treatment strategies supports a critical role of TNF-alpha in both local and systemic features of pauci- and polyarticular JIA. (See  <a class="medical medical_review" href="/d/html/6414.html" rel="external">"Polyarticular juvenile idiopathic arthritis: Clinical manifestations, diagnosis, and complications"</a> and  <a class="medical medical_review" href="/d/html/6400.html" rel="external">"Systemic juvenile idiopathic arthritis: Treatment", section on 'Biologic disease-modifying antirheumatic drug (DMARD) therapy'</a>.)</p><p>Surprisingly, the same strategy appears to be less effective in the systemic form of JIA. Preliminary clinical experience, however, suggests that patients with systemic JIA may show a much better response to therapy directed toward IL-1 or IL-6. In fact, good clinical response to the inhibition of IL-6 and/or IL-1 in systemic JIA is similar to that seen in autoinflammatory diseases with a known genetic cause, such as neonatal-onset multisystem inflammatory disease, in which the inflammatory response is triggered by the abnormalities in the innate immunity [<a href="#rid158">158</a>]. It has been suggested that the role of the adaptive immune response in systemic JIA may be rather limited compared with the other clinical forms of JIA. In contrast, the contribution of the innate immunity may be much more prominent, and systemic JIA should be viewed as an autoinflammatory syndrome. (See  <a class="medical medical_review" href="/d/html/5585.html" rel="external">"Cryopyrin-associated periodic syndromes and related disorders", section on 'Neonatal-onset multisystem inflammatory disease'</a> and  <a class="medical medical_review" href="/d/html/6400.html" rel="external">"Systemic juvenile idiopathic arthritis: Treatment", section on 'Biologic disease-modifying antirheumatic drug (DMARD) therapy'</a>.)</p><p class="headingAnchor" id="H30"><span class="h2">Macrophage activation syndrome</span><span class="headingEndMark"> — </span>Massive expansion of macrophages exhibiting hemophagocytic activity is the central feature of so-called "macrophage activation syndrome" (MAS), occasionally seen in patients with predominantly systemic JIA. The expansion of macrophages in this condition is associated with the uncontrolled proliferation of activated CD8+ T cells. Clinically, MAS shares strong similarities with familial hemophagocytic lymphohistiocytosis (FHLH), a usually fatal heritable disorder. (See  <a class="medical medical_review" href="/d/html/8384.html" rel="external">"Treatment and prognosis of hemophagocytic lymphohistiocytosis"</a> and  <a class="medical medical_review" href="/d/html/13512.html" rel="external">"Systemic juvenile idiopathic arthritis: Course, prognosis, and complications", section on 'Macrophage activation syndrome'</a>.)</p><p class="headingAnchor" id="H31"><span class="h2">Neutrophils</span><span class="headingEndMark"> — </span>Numbers of circulating neutrophils may be very high in patients with systemic JIA, and these cells may contribute to the amplification of the inflammatory response in this form of JIA. Neutrophil gene profiling in polyarticular JIA suggests an important role for neutrophils in disease pathogenesis of this subtype as well [<a href="#rid162">162</a>]. Evidence of the importance of inflammatory mediators released from neutrophils includes:</p><p class="bulletIndent1"><span class="glyph">●</span>Elevation of serum levels of a pair of calcium-binding S100 molecules (the myeloid-related proteins 8 and 14) by 120-fold and approximately 12-fold from children with systemic disease when compared with healthy children or those with other inflammatory diseases or infections, respectively [<a href="#rid163">163</a>].</p><p></p><p class="bulletIndent1"><span class="glyph">●</span>Increased serum levels of the calcium binding protein S100A12 (also called p6 or calgranulin C), a ligand for the receptor for advanced glycation end products (RAGE) and a mediator of inflammation are often present in untreated patients; average levels are much higher in those with systemic disease than in children with polyarticular or oligoarticular disease (mean serum concentrations of 3700 ng/mL, versus 395 and 325 ng/mL, respectively) [<a href="#rid164">164</a>].</p><p></p><p class="headingAnchor" id="H32"><span class="h2">B cells</span><span class="headingEndMark"> — </span>Although T cells are usually more numerous in inflamed synovial tissue, B cell activity appears to be enhanced in both peripheral blood and the synovial compartment. Synovial tissue specimens from JIA patients have significant numbers of immunoglobulin-synthesizing cells [<a href="#rid103">103</a>]. These cells tend to be focally aggregated. An increased number of B cells spontaneously producing immunoglobulins are also seen in the peripheral blood [<a href="#rid165">165,166</a>]. In addition, memory B cells in the synovium of JIA patients express costimulatory molecules (CD80/CD86) and may function as antigen-presenting cells and activate T cells [<a href="#rid167">167</a>].</p><p>Increased expression of genes related to B cells and decreased expression of genes related to cells of the myeloid compartment are seen in patients with oligoarticular JIA who had disease onset before age six years compared with those with a later age of onset [<a href="#rid168">168</a>]. These findings suggest that oligoarticular JIA with onset before six years of age may ultimately be determined to be a distinct disease.</p><p class="headingAnchor" id="H33"><span class="h3">Immunoglobulins</span><span class="headingEndMark"> — </span>The serum levels of immunoglobulins are elevated in a large proportion of patients with JRA [<a href="#rid169">169,170</a>]. In one series, for example, 37 percent of patients with JRA exhibited hyperglobulinemia in at least one immunoglobulin class, and elevation of globulins correlated with the activity of the disease [<a href="#rid170">170</a>]. Differences in immunoglobulin levels among different JIA clinical subgroups were also noted: Children with polyarticular and systemic disease had mean immunoglobulin levels that were higher than those with oligoarticular JIA. Elevated immunoglobulin A (IgA) levels were associated with the appearance of cartilage erosions.</p><p>Conversely, hypoglobulinemia has also been associated with JRA, and a selective decrease in serum IgA concentrations has been described in some patients [<a href="#rid170">170,171</a>].</p><p class="headingAnchor" id="H34"><span class="h3">Rheumatoid factors</span><span class="headingEndMark"> — </span>Rheumatoid factors (RFs) are only rarely detected in patients with JIA by the classic Rose-Waller reaction or latex-fixation method; the probability of RF positivity increases with the child's age and the duration of the disease. (See  <a class="medical medical_review" href="/d/html/1824.html" rel="external">"Rheumatoid factor: Biology and utility of measurement"</a>.)</p><p>Allen and Kunkel demonstrated a so-called hidden RF, defined as IgM 19S antiglobulin [<a href="#rid172">172</a>]. This antiglobulin is "hidden" because of its occupied binding sites. Gel filtration at acid pH dissociates IgM from IgG and allows IgM RF to fix complement in the hemolytic assay. Hidden RFs have been correlated with clinically active disease in approximately two-thirds of patients with JRA [<a href="#rid173">173,174</a>].</p><p class="headingAnchor" id="H35"><span class="h3">Antinuclear antibodies</span><span class="headingEndMark"> — </span>The reported incidence of antinuclear antibodies (ANAs) in patients with JRA varies from 4 to 88 percent depending upon the clinical subtype and the laboratory technique used [<a href="#rid175">175</a>]. ANAs are uncommon in systemic disease but are present in more than one-half of children with oligoarticular JIA. ANAs are occasionally found in patients with polyarticular disease, most often in those who are RF positive. (See  <a class="medical medical_review" href="/d/html/1822.html" rel="external">"Measurement and clinical significance of antinuclear antibodies"</a>.)</p><p>Children who are ANA positive carry an especially high risk of chronic anterior uveitis [<a href="#rid175">175,176</a>]. Local synthesis of ANA in the eyes of patients with chronic iridocyclitis has been noted [<a href="#rid177">177</a>].</p><p>The specificity of these antibodies remains to be determined. Some studies indicate that ANAs in JRA are directed against a ribonucleoprotein that requires both RNA and protein components for antigenic integrity [<a href="#rid178">178</a>]. Others dispute this and find that ANA specificity profiles are highly individual and do not correlate with disease subtype or activity [<a href="#rid179">179</a>].</p><p>Antibodies to many antigens typical for other rheumatic diseases (eg, the extractable nuclear protein, centromere proteins, topoisomerase [Scl-70], Ro, La, and double-stranded DNA) are generally absent in JIA. Antibodies to the 45 kDa DEK nuclear antigen, a putative oncoprotein, have been associated with the oligoarticular type of JIA, particularly in patients with a history of iridocyclitis [<a href="#rid180">180</a>]. However, these antibodies are present in other rheumatic diseases [<a href="#rid181">181</a>]. Anticollagen [<a href="#rid182">182</a>], antiretinal [<a href="#rid183">183-185</a>], and anti-T cell antibodies have been described, but their relevance to the pathogenesis of JIA is uncertain [<a href="#rid186">186-188</a>].</p><p class="headingAnchor" id="H36"><span class="h2">Immune complexes</span><span class="headingEndMark"> — </span>Abnormal antibody production and defects in clearance by the reticuloendothelial system may result in an increased concentration of circulating immune complexes in serum and synovial fluid.</p><p>Attempts at quantitating immune complexes in serum have yielded conflicting results:</p><p class="bulletIndent1"><span class="glyph">●</span>Using a C1q binding assay, 22 percent of patients with JRA have elevated levels of circulating immune complexes, and the concentration of circulating immune complexes may correlate with the severity of the disease [<a href="#rid189">189</a>].</p><p></p><p class="bulletIndent1"><span class="glyph">●</span>Using the polyethylene glycol precipitation method, circulating immune complexes were found in the serum of only 1 out of 13 children with JRA [<a href="#rid190">190</a>].</p><p></p><p class="bulletIndent1"><span class="glyph">●</span>Using four different techniques, elevated levels of circulating immune complexes were demonstrated in 79 percent of patients with JRA by at least one method [<a href="#rid191">191</a>].</p><p></p><p>Findings in synovial fluid have also been inconsistent:</p><p class="bulletIndent1"><span class="glyph">●</span>Using the C1q binding assay, elevated levels of immune complexes were found in joint fluid from some children, but the results varied substantially among patients [<a href="#rid192">192</a>].</p><p></p><p class="bulletIndent1"><span class="glyph">●</span>Using the Raji cell method, normal levels of circulating immune complexes have been found in synovial fluids of patients with oligoarticular JIA [<a href="#rid141">141</a>].</p><p></p><p>A general impression is that circulating immune complexes may contribute to the perpetuation of chronic inflammation in JIA but do not play a major role in its pathogenesis.</p><p class="headingAnchor" id="H37"><span class="h2">Complement activation</span><span class="headingEndMark"> — </span>Despite these conflicting results, many investigators think that deposition of circulating immune complexes in synovial compartments may result in complement system activation, which in turn causes tissue damage. Some evidence to support this hypothesis has been obtained.</p><p class="bulletIndent1"><span class="glyph">●</span>In one report, complement degradation products C3c and C3d were elevated in the serum of 7 of 10 patients with active systemic disease, in 16 of 29 with active polyarthritis, in 7 of 20 with active pauciarthritis, but in only 2 of 20 with inactive disease [<a href="#rid193">193</a>]. C3c and C3d were not increased in synovial fluid. Elevated serum C3d has also been described in other studies [<a href="#rid192">192</a>].</p><p></p><p class="bulletIndent1"><span class="glyph">●</span>Systemic and, to a lesser degree, polyarticular subgroups may have elevations of both C4d/C4 and C3d/C3 ratios, while only the C3d level may be increased in oligoarticular disease [<a href="#rid194">194</a>].</p><p></p><p>The complement activation cascade (C1-C5) participates in inflammatory reactions mostly by releasing anaphylatoxins, while the terminal cascade results in the formation of the cytolytic macromolecular complex. The entire cascade is involved in the activation process both in peripheral blood and the synovial compartment in patients with JRA [<a href="#rid195">195</a>]. Weak staining for deposits of C3b, C3dg, and the membrane attack complex has also been noted. However, no association was noted between clinical activity and the degree of complement activation. This may in part be due to complement activation by C-reactive protein, a process that is not antigen specific, rather than by immune complexes [<a href="#rid195">195</a>]. (See  <a class="medical medical_review" href="/d/html/3968.html" rel="external">"Complement pathways"</a>.)</p><p class="headingAnchor" id="H38"><span class="h2">Systemic JIA</span><span class="headingEndMark"> — </span>Data suggest that the underlying pathogenesis of systemic JIA is based upon an uncontrolled innate immune system that results in an autoinflammatory disease. In this disease, there is activation of the vascular endothelium with expression of leucocyte adhesion molecules (E-selectin, vascular cell adhesion molecule 1, and intercellular adhesion molecule 1), subsequent recruitment of neutrophils, and monocytes, and secretion of proinflammatory cytokines (TNF-alpha, IL-1, and IL-6) and S100 proteins [<a href="#rid196">196</a>]. (See <a class="local">'Recruitment of cells into synovium'</a> above and <a class="local">'Macrophages/fibroblasts'</a> above and <a class="local">'Neutrophils'</a> above.)</p><p class="headingAnchor" id="H2015483576"><span class="h1">SOCIETY GUIDELINE LINKS</span><span class="headingEndMark"> — </span>Links to society and government-sponsored guidelines from selected countries and regions around the world are provided separately. (See  <a class="medical medical_society_guidelines" href="/d/html/118570.html" rel="external">"Society guideline links: Uveitis"</a>.)</p><p class="headingAnchor" id="H29719575"><span class="h1">SUMMARY</span></p><p class="bulletIndent1"><span class="glyph">●</span>The lack of standard diagnostic criteria for juvenile idiopathic arthritis (JIA; which includes the previous grouping of juvenile rheumatoid arthritis [JRA] or juvenile chronic arthritis [JCA]) has complicated epidemiologic studies, including the determination of incidence and prevalence  (<a class="graphic graphic_table graphicRef78901" href="/d/graphic/78901.html" rel="external">table 1</a>). JIA appears to be less common in African American and Asian American populations in the United States. In most populations, the female-to-male ratio ranges from 2:1 to 3:1. However, these ratios depend upon the age at onset and the type of the disease. The peak incidence is one to three years of age, although this varies depending upon sex and type of disease. (See <a class="local">'Epidemiology'</a> above.)</p><p></p><p class="bulletIndent1"><span class="glyph">●</span>The pathogenesis and etiology of JIA are unclear. As with most autoimmune disorders, interactions among genetic factors, immune mechanisms, and environmental exposures are thought to contribute in most cases. (See <a class="local">'Pathogenesis'</a> above.)</p><p></p><p class="bulletIndent1"><span class="glyph">●</span>Patterns of inheritance consistent with Mendelian or monogenic inheritance have not been observed in JIA. The level of risk to family members of a proband appears to be only mildly increased in most cases. Multiple human leukocyte antigen (HLA) loci are associated with the development of JIA, with specific disease subtypes being linked to specific HLA alleles. Patients with early-onset oligoarticular JIA, which has a relatively high concordance among siblings, constitute the subtype with the most distinctive HLA associations. Some genes operative in JIA appear to have a "window-of-effect," during which time they may contribute risk of disease but be neutral or even protective at other times. (See <a class="local">'Predisposing major histocompatibility complex genes'</a> above.)</p><p></p><p class="bulletIndent1"><span class="glyph">●</span>The major clinical manifestation of JIA is persistent joint swelling that results from the combination of synovial fluid accumulation and synovial thickening. Such swelling may cause deformities of affected joints due to stretching of periarticular ligaments and tendons. In addition, enzymes released by inflammatory cells within the synovium or synovial fluid may result in degradation of the collagen and proteoglycan matrix of the articular cartilage. Activation of osteoclasts resulting from the production of cytokines by cells within the mass of inflammatory tissue is probably the final pathway of juxtaarticular bone demineralization and bone erosions. (See <a class="local">'Pathobiology'</a> above.)</p><p></p><p class="bulletIndent1"><span class="glyph">●</span>One of the pathologic hallmarks of JIA is the tumor-like expansion of inflamed synovial tissue, or pannus, which causes much of the joint damage. Pannus results from the proliferation of synoviocytes and invasion of the synovial tissue by inflammatory cells, including lymphocytes, macrophages, and dendritic cells, recruited from the peripheral circulation. Infiltration into the synovium depends upon the interplay of vascular factors, cytokines, adhesion molecules, and chemokines. Various inflammatory cells are also found in the synovial fluid. As the disease progresses, pannus spreads over the synovial space and adheres to intraarticular cartilage. It is in the areas of pannus-cartilage junction where the cartilage eventually degrades. (See <a class="local">'Pathobiology'</a> above.)</p><p></p></div><div class="headingAnchor" id="references"><ol id="reference"><li><a class="nounderline abstract_t">Towner SR, Michet CJ Jr, O'Fallon WM, Nelson AM. The epidemiology of juvenile arthritis in Rochester, Minnesota 1960-1979. Arthritis Rheum 1983; 26:1208.</a></li><li><a class="nounderline abstract_t">Peterson LS, Mason T, Nelson AM, et al. Juvenile rheumatoid arthritis in Rochester, Minnesota 1960-1993. Is the epidemiology changing? Arthritis Rheum 1996; 39:1385.</a></li><li><a class="nounderline abstract_t">Laaksonen AL. A prognostic study of juvenile rheumatoid arthritis. Analysis of 544 cases. Acta Paediatr Scand 1966; :1.</a></li><li><a class="nounderline abstract_t">Kunnamo I, Kallio P, Pelkonen P. Incidence of arthritis in urban Finnish children. A prospective study. Arthritis Rheum 1986; 29:1232.</a></li><li><a class="nounderline abstract_t">Gäre BA, Fasth A. Epidemiology of juvenile chronic arthritis in southwestern Sweden: a 5-year prospective population study. Pediatrics 1992; 90:950.</a></li><li><a class="nounderline abstract_t">Oen K, Fast M, Postl B. Epidemiology of juvenile rheumatoid arthritis in Manitoba, Canada, 1975-92: cycles in incidence. J Rheumatol 1995; 22:745.</a></li><li><a class="nounderline abstract_t">Symmons DP, Jones M, Osborne J, et al. Pediatric rheumatology in the United Kingdom: data from the British Pediatric Rheumatology Group National Diagnostic Register. J Rheumatol 1996; 23:1975.</a></li><li><a class="nounderline abstract_t">Gewanter HL, Baum J. The frequency of juvenile arthritis. J Rheumatol 1989; 16:556.</a></li><li><a class="nounderline abstract_t">Lawrence RC, Helmick CG, Arnett FC, et al. Estimates of the prevalence of arthritis and selected musculoskeletal disorders in the United States. Arthritis Rheum 1998; 41:778.</a></li><li><a class="nounderline abstract_t">Graham TB, Glass DN. Juvenile rheumatoid arthritis: ethnic differences in diagnostic types. J Rheumatol 1997; 24:1677.</a></li><li><a class="nounderline abstract_t">Schwartz MM, Simpson P, Kerr KL, Jarvis JN. Juvenile rheumatoid arthritis in African Americans. J Rheumatol 1997; 24:1826.</a></li><li><a class="nounderline abstract_t">Fujikawa S, Okuni M. Clinical analysis of 570 cases with juvenile rheumatoid arthritis: results of a nationwide retrospective survey in Japan. Acta Paediatr Jpn 1997; 39:245.</a></li><li><a class="nounderline abstract_t">Sullivan DB, Cassidy JT, Petty RE. Pathogenic implications of age of onset in juvenile rheumatoid arthritis. Arthritis Rheum 1975; 18:251.</a></li><li><a class="nounderline abstract_t">Schaller JG. Juvenile rheumatoid arthritis: Series 1. Arthritis Rheum 1977; 20:165.</a></li><li><a class="nounderline abstract_t">Haffejee IE, Raga J, Coovadia HM. Juvenile chronic arthritis in black and Indian South African children. S Afr Med J 1984; 65:510.</a></li><li><a class="nounderline abstract_t">Van Kerckhove C, Balakrishnan K, Levinson JE, et al. HLA and altered sex ratios in juvenile rheumatoid arthritis sibships. Hum Immunol 1988; 22:227.</a></li><li><a class="nounderline abstract_t">Schaller J, Kupfer C, Wedgwood RJ. Iridocyclitis in juvenile rheumatoid arthritis. Pediatrics 1969; 44:92.</a></li><li><a class="nounderline abstract_t">Cassidy JT, Sullivan DB, Petty RE. Clinical patterns of chronic iridocyclitis in children with juvenile rheumatoid arthritis. Arthritis Rheum 1977; 20:224.</a></li><li><a class="nounderline abstract_t">Aaron S, Fraser PA, Jackson JM, et al. Sex ratio and sibship size in juvenile rheumatoid arthritis kindreds. Arthritis Rheum 1985; 28:753.</a></li><li><a class="nounderline abstract_t">Rachelefsky GS, Terasaki PI, Katz R, Stiehm ER. Increased prevalence of W27 in juvenile rheumatoid arthritis. N Engl J Med 1974; 290:892.</a></li><li><a class="nounderline abstract_t">Schaller JG, Ochs HD, Thomas ED, et al. Histocompatibility antigens in childhood-onset arthritis. J Pediatr 1976; 88:926.</a></li><li><a class="nounderline abstract_t">Pritchard MH, Matthews N, Munro J. Antibodies to influenza A in a cluster of children with juvenile chronic arthritis. Br J Rheumatol 1988; 27:176.</a></li><li><a class="nounderline abstract_t">Lindsley CB. Seasonal variation in systemic onset juvenile rheumatoid arthritis. Arthritis Rheum 1987; 30:838.</a></li><li><a class="nounderline abstract_t">Feldman BM, Birdi N, Boone JE, et al. Seasonal onset of systemic-onset juvenile rheumatoid arthritis. J Pediatr 1996; 129:513.</a></li><li><a class="nounderline abstract_t">Ansell BM, Bywaters EG, Lawrence JS. Familial aggregation and twin studies in Still's disease. Juvenile chronic polyarthritis. Rheumatology 1969; 2:37.</a></li><li><a class="nounderline abstract_t">Rossen RD, Brewer EJ, Sharp RM, et al. Familial rheumatoid arthritis: linkage of HLA to disease susceptibility locus in four families where proband presented with juvenile rheumatoid arthritis. J Clin Invest 1980; 65:629.</a></li><li><a class="nounderline abstract_t">Moroldo MB, Tague BL, Shear ES, et al. Juvenile rheumatoid arthritis in affected sibpairs. Arthritis Rheum 1997; 40:1962.</a></li><li><a class="nounderline abstract_t">Moroldo MB, Chaudhari M, Shear E, et al. Juvenile rheumatoid arthritis affected sibpairs: extent of clinical phenotype concordance. Arthritis Rheum 2004; 50:1928.</a></li><li><a class="nounderline abstract_t">Clemens LE, Albert E, Ansell BM. Sibling pairs affected by chronic arthritis of childhood: evidence for a genetic predisposition. J Rheumatol 1985; 12:108.</a></li><li><a class="nounderline abstract_t">Rudolf MC, Genel M, Tamborlane WV Jr, Dwyer JM. Juvenile rheumatoid arthritis in children with diabetes mellitus. J Pediatr 1981; 99:519.</a></li><li><a class="nounderline abstract_t">Firooz A, Mazhar A, Ahmed AR. Prevalence of autoimmune diseases in the family members of patients with pemphigus vulgaris. J Am Acad Dermatol 1994; 31:434.</a></li><li><a class="nounderline abstract_t">Nepom BS, Glass DN. Juvenile rheumatoid arthritis and HLA: report of the Park City III workshop. J Rheumatol Suppl 1992; 33:70.</a></li><li><a class="nounderline abstract_t">Stastny P, Fink CW. Different HLA-D associations in adult and juvenile rheumatoid arthritis. J Clin Invest 1979; 63:124.</a></li><li><a class="nounderline abstract_t">Van Kerckhove C, Melin-Aldana H, Elma MS, et al. A distinct HLA-DRw8 haplotype characterizes patients with juvenile rheumatoid arthritis. Immunogenetics 1990; 32:304.</a></li><li><a class="nounderline abstract_t">Glass D, Litvin D, Wallace K, et al. Early-onset pauciarticular juvenile rheumatoid arthritis associated with human leukocyte antigen-DRw5, iritis, and antinuclear antibody. J Clin Invest 1980; 66:426.</a></li><li><a class="nounderline abstract_t">Howard JF, Sigsbee A, Glass DN. HLA genetics and inherited predisposition to JRA. J Rheumatol 1985; 12:7.</a></li><li><a class="nounderline abstract_t">Førre O, Dobloug JH, Høyeraal HM, Thorsby E. HLA antigens in juvenile arthritis. Genetic basis for the different subtypes. Arthritis Rheum 1983; 26:35.</a></li><li><a class="nounderline abstract_t">Reekers P, Schretlen ED, van de Putte LB. Increase of HLA-"DRw6" in patients with juvenile chronic arthritis. Tissue Antigens 1983; 22:283.</a></li><li><a class="nounderline abstract_t">Hoffman RW, Shaw S, Francis LC, et al. HLA-DP antigens in patients with pauciarticular juvenile rheumatoid arthritis. Arthritis Rheum 1986; 29:1057.</a></li><li><a class="nounderline abstract_t">Odum N, Morling N, Friis J, et al. Increased frequency of HLA-DPw2 in pauciarticular onset juvenile chronic arthritis. Tissue Antigens 1986; 28:245.</a></li><li><a class="nounderline abstract_t">Oen K, Petty RE, Schroeder ML. An association between HLA-A2 and juvenile rheumatoid arthritis in girls. J Rheumatol 1982; 9:916.</a></li><li><a class="nounderline abstract_t">Melin-Aldana H, Giannini EH, Taylor J, et al. Human leukocyte antigen-DRB1*1104 in the chronic iridocyclitis of pauciarticular juvenile rheumatoid arthritis. J Pediatr 1992; 121:56.</a></li><li><a class="nounderline abstract_t">van Kerckhove C, Luyrink L, Taylor J, et al. HLA-DQA1*0101 haplotypes and disease outcome in early onset pauciarticular juvenile rheumatoid arthritis. J Rheumatol 1991; 18:874.</a></li><li><a class="nounderline abstract_t">Ploski R, Vinje O, Rønningen KS, et al. HLA class II alleles and heterogeneity of juvenile rheumatoid arthritis. DRB1*0101 may define a novel subset of the disease. Arthritis Rheum 1993; 36:465.</a></li><li><a class="nounderline abstract_t">Paul C, Schoenwald U, Truckenbrodt H, et al. HLA-DP/DR interaction in early onset pauciarticular juvenile chronic arthritis. Immunogenetics 1993; 37:442.</a></li><li><a class="nounderline abstract_t">Hall PJ, Burman SJ, Laurent MR, et al. Genetic susceptibility to early onset pauciarticular juvenile chronic arthritis: a study of HLA and complement markers in 158 British patients. Ann Rheum Dis 1986; 45:464.</a></li><li><a class="nounderline abstract_t">Fernandez-Viña MA, Fink CW, Stastny P. HLA antigens in juvenile arthritis. Pauciarticular and polyarticular juvenile arthritis are immunogenetically distinct. Arthritis Rheum 1990; 33:1787.</a></li><li><a class="nounderline abstract_t">Nepom BS, Nepom GT, Mickelson E, et al. Specific HLA-DR4-associated histocompatibility molecules characterize patients with seropositive juvenile rheumatoid arthritis. J Clin Invest 1984; 74:287.</a></li><li><a class="nounderline abstract_t">Ombrello MJ, Remmers EF, Tachmazidou I, et al. HLA-DRB1*11 and variants of the MHC class II locus are strong risk factors for systemic juvenile idiopathic arthritis. Proc Natl Acad Sci U S A 2015; 112:15970.</a></li><li><a class="nounderline abstract_t">Ombrello MJ, Arthur VL, Remmers EF, et al. Genetic architecture distinguishes systemic juvenile idiopathic arthritis from other forms of juvenile idiopathic arthritis: clinical and therapeutic implications. Ann Rheum Dis 2017; 76:906.</a></li><li><a class="nounderline abstract_t">Gregersen PK, Silver J, Winchester RJ. The shared epitope hypothesis. An approach to understanding the molecular genetics of susceptibility to rheumatoid arthritis. Arthritis Rheum 1987; 30:1205.</a></li><li><a class="nounderline abstract_t">Willkens RF, Nepom GT, Marks CR, et al. Association of HLA-Dw16 with rheumatoid arthritis in Yakima Indians. Further evidence for the "shared epitope" hypothesis. Arthritis Rheum 1991; 34:43.</a></li><li><a class="nounderline abstract_t">Murray KJ, Moroldo MB, Donnelly P, et al. Age-specific effects of juvenile rheumatoid arthritis-associated HLA alleles. Arthritis Rheum 1999; 42:1843.</a></li><li><a class="nounderline abstract_t">Grom AA, von Knorre C, Murray KJ, et al. T-cell receptor BV6S1 null alleles and HLA-DR1 haplotypes in polyarticular outcome juvenile rheumatoid arthritis. Hum Immunol 1996; 45:152.</a></li><li><a class="nounderline abstract_t">McLaughlin JF, Schaller J, Wedgwood RJ. Arthritis and immunodeficiency. J Pediatr 1972; 81:801.</a></li><li><a class="nounderline abstract_t">McDowell TL, Symons JA, Ploski R, et al. A genetic association between juvenile rheumatoid arthritis and a novel interleukin-1 alpha polymorphism. Arthritis Rheum 1995; 38:221.</a></li><li><a class="nounderline abstract_t">Date Y, Seki N, Kamizono S, et al. Identification of a genetic risk factor for systemic juvenile rheumatoid arthritis in the 5'-flanking region of the TNFalpha gene and HLA genes. Arthritis Rheum 1999; 42:2577.</a></li><li><a class="nounderline abstract_t">Maksymowych WP, Gabriel CA, Luyrink L, et al. Polymorphism in a T-cell receptor variable gene is associated with susceptibility to a juvenile rheumatoid arthritis subset. Immunogenetics 1992; 35:257.</a></li><li><a class="nounderline abstract_t">Fishman D, Faulds G, Jeffery R, et al. The effect of novel polymorphisms in the interleukin-6 (IL-6) gene on IL-6 transcription and plasma IL-6 levels, and an association with systemic-onset juvenile chronic arthritis. J Clin Invest 1998; 102:1369.</a></li><li><a class="nounderline abstract_t">Crawley E, Kay R, Sillibourne J, et al. Polymorphic haplotypes of the interleukin-10 5' flanking region determine variable interleukin-10 transcription and are associated with particular phenotypes of juvenile rheumatoid arthritis. Arthritis Rheum 1999; 42:1101.</a></li><li><a class="nounderline abstract_t">Sullivan KE, McDonald-McGinn DM, Driscoll DA, et al. Juvenile rheumatoid arthritis-like polyarthritis in chromosome 22q11.2 deletion syndrome (DiGeorge anomalad/velocardiofacial syndrome/conotruncal anomaly face syndrome). Arthritis Rheum 1997; 40:430.</a></li><li><a class="nounderline abstract_t">Donn RP, Davies EJ, Holt PL, et al. Increased frequency of TAP2B in early onset pauciarticular juvenile chronic arthritis. Ann Rheum Dis 1994; 53:261.</a></li><li><a class="nounderline abstract_t">Pryhuber KG, Murray KJ, Donnelly P, et al. Polymorphism in the LMP2 gene influences disease susceptibility and severity in HLA-B27 associated juvenile rheumatoid arthritis. J Rheumatol 1996; 23:747.</a></li><li><a class="nounderline abstract_t">Donn RP, Shelley E, Ollier WE, et al. A novel 5'-flanking region polymorphism of macrophage migration inhibitory factor is associated with systemic-onset juvenile idiopathic arthritis. Arthritis Rheum 2001; 44:1782.</a></li><li><a class="nounderline abstract_t">Donn R, Alourfi Z, De Benedetti F, et al. Mutation screening of the macrophage migration inhibitory factor gene: positive association of a functional polymorphism of macrophage migration inhibitory factor with juvenile idiopathic arthritis. Arthritis Rheum 2002; 46:2402.</a></li><li><a class="nounderline abstract_t">Zeggini E, Thomson W, Kwiatkowski D, et al. Linkage and association studies of single-nucleotide polymorphism-tagged tumor necrosis factor haplotypes in juvenile oligoarthritis. Arthritis Rheum 2002; 46:3304.</a></li><li><a class="nounderline abstract_t">Hinks A, Barton A, John S, et al. Association between the PTPN22 gene and rheumatoid arthritis and juvenile idiopathic arthritis in a UK population: further support that PTPN22 is an autoimmunity gene. Arthritis Rheum 2005; 52:1694.</a></li><li><a class="nounderline abstract_t">Rosen P, Thompson S, Glass D. Non-HLA gene polymorphisms in juvenile rheumatoid arthritis. Clin Exp Rheumatol 2003; 21:650.</a></li><li><a class="nounderline abstract_t">Ogilvie EM, Fife MS, Thompson SD, et al. The -174G allele of the interleukin-6 gene confers susceptibility to systemic arthritis in children: a multicenter study using simplex and multiplex juvenile idiopathic arthritis families. Arthritis Rheum 2003; 48:3202.</a></li><li><a class="nounderline abstract_t">Smerdel A, Lie BA, Ploski R, et al. A gene in the telomeric HLA complex distinct from HLA-A is involved in predisposition to juvenile idiopathic arthritis. Arthritis Rheum 2002; 46:1614.</a></li><li><a class="nounderline abstract_t">Thompson SD, Moroldo MB, Guyer L, et al. A genome-wide scan for juvenile rheumatoid arthritis in affected sibpair families provides evidence of linkage. Arthritis Rheum 2004; 50:2920.</a></li><li><a class="nounderline abstract_t">Hinks A, Cobb J, Sudman M, et al. Investigation of rheumatoid arthritis susceptibility loci in juvenile idiopathic arthritis confirms high degree of overlap. Ann Rheum Dis 2012; 71:1117.</a></li><li><a class="nounderline abstract_t">Thompson SD, Marion MC, Sudman M, et al. Genome-wide association analysis of juvenile idiopathic arthritis identifies a new susceptibility locus at chromosomal region 3q13. Arthritis Rheum 2012; 64:2781.</a></li><li><a class="nounderline abstract_t">Hinks A, Cobb J, Marion MC, et al. Dense genotyping of immune-related disease regions identifies 14 new susceptibility loci for juvenile idiopathic arthritis. Nat Genet 2013; 45:664.</a></li><li><a class="nounderline abstract_t">Hinks A, Marion MC, Cobb J, et al. Brief Report: The Genetic Profile of Rheumatoid Factor-Positive Polyarticular Juvenile Idiopathic Arthritis Resembles That of Adult Rheumatoid Arthritis. Arthritis Rheumatol 2018; 70:957.</a></li><li><a class="nounderline abstract_t">Murray K, Thompson SD, Glass DN. Pathogenesis of juvenile chronic arthritis: genetic and environmental factors. Arch Dis Child 1997; 77:530.</a></li><li><a class="nounderline abstract_t">Ellis JA, Munro JE, Ponsonby AL. Possible environmental determinants of juvenile idiopathic arthritis. Rheumatology (Oxford) 2010; 49:411.</a></li><li><a class="nounderline abstract_t">Inman RD. The role of infection in chronic arthritis. J Rheumatol Suppl 1992; 33:98.</a></li><li><a class="nounderline abstract_t">Ogra PL, Chiba Y, Ogra SS, et al. Rubella-virus infection in juvenile rheumatoid arthritis. Lancet 1975; 1:1157.</a></li><li><a class="nounderline abstract_t">Linnemann CC Jr, Levinson JE, Buncher CR, Schiff GM. Rubella antibody levels in juvenile rheumatoid arthritis. Ann Rheum Dis 1975; 34:354.</a></li><li><a class="nounderline abstract_t">Al-Nakib W, Majeed HA. Serologic studies on the association of rubella virus infection and juvenile rheumatoid arthritis. Ann Trop Paediatr 1981; 1:93.</a></li><li><a class="nounderline abstract_t">Chantler JK, Tingle AJ, Petty RE. Persistent rubella virus infection associated with chronic arthritis in children. N Engl J Med 1985; 313:1117.</a></li><li><a class="nounderline abstract_t">Korematsu S, Miyahara H, Kawano T, et al. A relapse of systemic type juvenile idiopathic arthritis after a rubella vaccination in a patient during a long-term remission period. Vaccine 2009; 27:5041.</a></li><li><a class="nounderline abstract_t">Albani S. Infection and molecular mimicry in autoimmune diseases of childhood. Clin Exp Rheumatol 1994; 12 Suppl 10:S35.</a></li><li><a class="nounderline abstract_t">Massa M, Mazzoli F, Pignatti P, et al. Proinflammatory responses to self HLA epitopes are triggered by molecular mimicry to Epstein-Barr virus proteins in oligoarticular juvenile idiopathic arthritis. Arthritis Rheum 2002; 46:2721.</a></li><li><a class="nounderline abstract_t">Maximov AA, Shaikov AV, Lovell DJ, et al. Chlamydial associated syndrome of arthritis and eye involvement in young children. J Rheumatol 1992; 19:1794.</a></li><li><a class="nounderline abstract_t">Lehmann HW, Knöll A, Küster RM, Modrow S. Frequent infection with a viral pathogen, parvovirus B19, in rheumatic diseases of childhood. Arthritis Rheum 2003; 48:1631.</a></li><li><a class="nounderline abstract_t">Sieper J, Braun J, Döring E, et al. Aetiological role of bacteria associated with reactive arthritis in pauciarticular juvenile chronic arthritis. Ann Rheum Dis 1992; 51:1208.</a></li><li><a class="nounderline abstract_t">Life P, Hassell A, Williams K, et al. Responses to gram negative enteric bacterial antigens by synovial T cells from patients with juvenile chronic arthritis: recognition of heat shock protein HSP60. J Rheumatol 1993; 20:1388.</a></li><li><a class="nounderline abstract_t">Horton DB, Scott FI, Haynes K, et al. Antibiotic Exposure and Juvenile Idiopathic Arthritis: A Case-Control Study. Pediatrics 2015; 136:e333.</a></li><li><a class="nounderline abstract_t">Arvonen M, Virta LJ, Pokka T, et al. Repeated exposure to antibiotics in infancy: a predisposing factor for juvenile idiopathic arthritis or a sign of this group's greater susceptibility to infections? J Rheumatol 2015; 42:521.</a></li><li><a class="nounderline abstract_t">Førre O, Dobloug JH, Natvig JB. Augmented numbers of HLA-DR-positive T lymphocytes in the synovial fluid and synovial tissue of patients with rheumatoid arthritis and juvenile rheumatoid arthritis: in vivo-activated T lymphocytes are potent stimulators in the mixed lymphocyte reaction. Scand J Immunol 1982; 15:227.</a></li><li><a class="nounderline abstract_t">Eberhard BA, Laxer RM, Andersson U, Silverman ED. Local synthesis of both macrophage and T cell cytokines by synovial fluid cells from children with juvenile rheumatoid arthritis. Clin Exp Immunol 1994; 96:260.</a></li><li><a class="nounderline abstract_t">Wynne-Roberts CR, Anderson CH, Turano AM, Baron M. Light- and electron-microscopic findings of juvenile rheumatoid arthritis synovium: comparison with normal juvenile synovium. Semin Arthritis Rheum 1978; 7:287.</a></li><li><a class="nounderline abstract_t">Wynne-Roberts CR, Anderson C. Light- and electron-microscopic studies of normal juvenile human synovium. Semin Arthritis Rheum 1978; 7:279.</a></li><li><a class="nounderline abstract_t">Ziff M. Role of the endothelium in chronic inflammatory synovitis. Arthritis Rheum 1991; 34:1345.</a></li><li><a class="nounderline abstract_t">Scola MP, Imagawa T, Boivin GP, et al. Expression of angiogenic factors in juvenile rheumatoid arthritis: correlation with revascularization of human synovium engrafted into SCID mice. Arthritis Rheum 2001; 44:794.</a></li><li><a class="nounderline abstract_t">Maeno N, Takei S, Imanaka H, et al. Increased circulating vascular endothelial growth factor is correlated with disease activity in polyarticular juvenile rheumatoid arthritis. J Rheumatol 1999; 26:2244.</a></li><li><a class="nounderline abstract_t">Bosco MC, Delfino S, Ferlito F, et al. The hypoxic synovial environment regulates expression of vascular endothelial growth factor and osteopontin in juvenile idiopathic arthritis. J Rheumatol 2009; 36:1318.</a></li><li><a class="nounderline abstract_t">Finnegan S, Clarke S, Gibson D, et al. Synovial membrane immunohistology in early untreated juvenile idiopathic arthritis: differences between clinical subgroups. Ann Rheum Dis 2011; 70:1842.</a></li><li><a class="nounderline abstract_t">Klareskog L, Forsum U, Scheynius A, et al. Evidence in support of a self-perpetuating HLA-DR-dependent delayed-type cell reaction in rheumatoid arthritis. Proc Natl Acad Sci U S A 1982; 79:3632.</a></li><li><a class="nounderline abstract_t">Murray KJ, Luyrink L, Grom AA, et al. Immunohistological characteristics of T cell infiltrates in different forms of childhood onset chronic arthritis. J Rheumatol 1996; 23:2116.</a></li><li><a class="nounderline abstract_t">Lindblad S, Klareskog L, Hedfors E, et al. Phenotypic characterization of synovial tissue cells in situ in different types of synovitis. Arthritis Rheum 1983; 26:1321.</a></li><li><a class="nounderline abstract_t">Nunez G, Ball EJ, Stastny P. Antigen presentation by adherent cells from human peripheral blood. Correlation between T-cell activation and expression of HLA-DQ and -DR antigens. Hum Immunol 1987; 19:29.</a></li><li><a class="nounderline abstract_t">Harding B, Knight SC. The distribution of dendritic cells in the synovial fluids of patients with arthritis. Clin Exp Immunol 1986; 63:594.</a></li><li><a class="nounderline abstract_t">Bergroth V, Konttinen YT, Pelkonen P, et al. Synovial fluid lymphocytes in different subtypes of juvenile rheumatoid arthritis. Arthritis Rheum 1988; 31:780.</a></li><li><a class="nounderline abstract_t">Jalkanen S, Steere AC, Fox RI, Butcher EC. A distinct endothelial cell recognition system that controls lymphocyte traffic into inflamed synovium. Science 1986; 233:556.</a></li><li><a class="nounderline abstract_t">Oen K, Danell G, Stewart S, et al. Adhesion of peripheral blood lymphocytes of children with arthritis to human umbilical vein endothelial cells. Clin Exp Immunol 1994; 95:415.</a></li><li><a class="nounderline abstract_t">Grom AA, Murray KJ, Luyrink L, et al. Patterns of expression of tumor necrosis factor alpha, tumor necrosis factor beta, and their receptors in synovia of patients with juvenile rheumatoid arthritis and juvenile spondylarthropathy. Arthritis Rheum 1996; 39:1703.</a></li><li><a class="nounderline abstract_t">Oppenheimer-Marks N, Brezinschek RI, Mohamadzadeh M, et al. Interleukin 15 is produced by endothelial cells and increases the transendothelial migration of T cells In vitro and in the SCID mouse-human rheumatoid arthritis model In vivo. J Clin Invest 1998; 101:1261.</a></li><li><a class="nounderline abstract_t">Scola MP, Thompson SD, Brunner HI, et al. Interferon-gamma:interleukin 4 ratios and associated type 1 cytokine expression in juvenile rheumatoid arthritis synovial tissue. J Rheumatol 2002; 29:369.</a></li><li><a class="nounderline abstract_t">Meazza C, Travaglino P, Pignatti P, et al. Macrophage migration inhibitory factor in patients with juvenile idiopathic arthritis. Arthritis Rheum 2002; 46:232.</a></li><li><a class="nounderline abstract_t">De Benedetti F, Meazza C, Vivarelli M, et al. Functional and prognostic relevance of the -173 polymorphism of the macrophage migration inhibitory factor gene in systemic-onset juvenile idiopathic arthritis. Arthritis Rheum 2003; 48:1398.</a></li><li><a class="nounderline abstract_t">Donn R, Alourfi Z, Zeggini E, et al. A functional promoter haplotype of macrophage migration inhibitory factor is linked and associated with juvenile idiopathic arthritis. Arthritis Rheum 2004; 50:1604.</a></li><li><a class="nounderline abstract_t">Odum N, Morling N, Platz P, et al. Increased prevalence of late stage T cell activation antigen (VLA-1) in active juvenile chronic arthritis. Ann Rheum Dis 1987; 46:846.</a></li><li><a class="nounderline abstract_t">Wedderburn LR, Woo P. Type 1 and type 2 immune responses in children: their relevance in juvenile arthritis. Springer Semin Immunopathol 1999; 21:361.</a></li><li><a class="nounderline abstract_t">Issekutz AC, Quinn PJ, Lang B, et al. Coexpression of chemokine receptors CCR5, CXCR3, and CCR4 and ligands for P- and E-selectin on T lymphocytes of patients with juvenile idiopathic arthritis. Arthritis Rheum 2011; 63:3467.</a></li><li><a class="nounderline abstract_t">De Maria A, Malnati M, Moretta A, et al. CD3+4-8-WT31-(T cell receptor gamma+) cells and other unusual phenotypes are frequently detected among spontaneously interleukin 2-responsive T lymphocytes present in the joint fluid in juvenile rheumatoid arthritis. A clonal analysis. Eur J Immunol 1987; 17:1815.</a></li><li><a class="nounderline abstract_t">Førre O, Thoen J, Dobloug JH, et al. Detection of T-lymphocyte subpopulation in the peripheral blood and the synovium of patients with rheumatoid arthritis and juvenile rheumatoid arthritis using monoclonal antibodies. Scand J Immunol 1982; 15:221.</a></li><li><a class="nounderline abstract_t">Haufe S, Haug M, Schepp C, et al. Impaired suppression of synovial fluid CD4+CD25- T cells from patients with juvenile idiopathic arthritis by CD4+CD25+ Treg cells. Arthritis Rheum 2011; 63:3153.</a></li><li><a class="nounderline abstract_t">Gold DP, Offner H, Sun D, et al. Analysis of T cell receptor beta chains in Lewis rats with experimental allergic encephalomyelitis: conserved complementarity determining region 3. J Exp Med 1991; 174:1467.</a></li><li><a class="nounderline abstract_t">Sioud M, Kjeldsen-Kragh J, Suleyman S, et al. Limited heterogeneity of T cell receptor variable region gene usage in juvenile rheumatoid arthritis synovial T cells. Eur J Immunol 1992; 22:2413.</a></li><li><a class="nounderline abstract_t">Grom AA, Thompson SD, Luyrink L, et al. Dominant T-cell-receptor beta chain variable region V beta 14+ clones in juvenile rheumatoid arthritis. Proc Natl Acad Sci U S A 1993; 90:11104.</a></li><li><a class="nounderline abstract_t">Thompson SD, Grom AA, Bailey S, et al. Patterns of T lymphocyte clonal expansion in HLA-typed patients with juvenile rheumatoid arthritis. J Rheumatol 1995; 22:1356.</a></li><li><a class="nounderline abstract_t">Wedderburn LR, Maini MK, Patel A, et al. Molecular fingerprinting reveals non-overlapping T cell oligoclonality between an inflamed site and peripheral blood. Int Immunol 1999; 11:535.</a></li><li><a class="nounderline abstract_t">Hingorani R, Choi IH, Akolkar P, et al. Clonal predominance of T cell receptors within the CD8+ CD45RO+ subset in normal human subjects. J Immunol 1993; 151:5762.</a></li><li><a class="nounderline abstract_t">Thompson SD, Murray KJ, Grom AA, et al. Comparative sequence analysis of the human T cell receptor beta chain in juvenile rheumatoid arthritis and juvenile spondylarthropathies: evidence for antigenic selection of T cells in the synovium. Arthritis Rheum 1998; 41:482.</a></li><li><a class="nounderline abstract_t">Sioud M, Førre O, Natvig JB. T cell receptor delta diversity of freshly isolated T lymphocytes in rheumatoid synovitis. Eur J Immunol 1991; 21:239.</a></li><li><a class="nounderline abstract_t">Kjeldsen-Kragh J, Quayle A, Kalvenes C, et al. T gamma delta cells in juvenile rheumatoid arthritis and rheumatoid arthritis. In the juvenile rheumatoid arthritis synovium the T gamma delta cells express activation antigens and are predominantly V delta 1+, and a significant proportion of these patients have elevated percentages of T gamma delta cells. Scand J Immunol 1990; 32:651.</a></li><li><a class="nounderline abstract_t">Shen Y, Li S, Quayle AJ, et al. TCR gamma/delta+ cell subsets in the synovial membranes of patients with rheumatoid arthritis and juvenile rheumatoid arthritis. Scand J Immunol 1992; 36:533.</a></li><li><a class="nounderline abstract_t">Kjeldsen-Kragh J, Quayle AJ, Vinje O, et al. A high proportion of the V delta 1+ synovial fluid gamma delta T cells in juvenile rheumatoid arthritis patients express the very early activation marker CD69, but carry the high molecular weight isoform of the leucocyte common antigen (CD45RA). Clin Exp Immunol 1993; 91:202.</a></li><li><a class="nounderline abstract_t">Born WK, O'Brien RL, Modlin RL. Antigen specificity of gamma delta T lymphocytes. FASEB J 1991; 5:2699.</a></li><li><a class="nounderline abstract_t">Söderström K, Halapi E, Nilsson E, et al. Synovial cells responding to a 65-kDa mycobacterial heat shock protein have a high proportion of a TcR gamma delta subtype uncommon in peripheral blood. Scand J Immunol 1990; 32:503.</a></li><li><a class="nounderline abstract_t">De Graeff-Meeder ER, van der Zee R, Rijkers GT, et al. Recognition of human 60 kD heat shock protein by mononuclear cells from patients with juvenile chronic arthritis. Lancet 1991; 337:1368.</a></li><li><a class="nounderline abstract_t">Gaston JS. Heat shock proteins and arthritis--new readers start here. Autoimmunity 1997; 26:33.</a></li><li><a class="nounderline abstract_t">Quayle AJ, Chomarat P, Miossec P, et al. Rheumatoid inflammatory T-cell clones express mostly Th1 but also Th2 and mixed (Th0-like) cytokine patterns. Scand J Immunol 1993; 38:75.</a></li><li><a class="nounderline abstract_t">de Kleer IM, Kamphuis SM, Rijkers GT, et al. The spontaneous remission of juvenile idiopathic arthritis is characterized by CD30+ T cells directed to human heat-shock protein 60 capable of producing the regulatory cytokine interleukin-10. Arthritis Rheum 2003; 48:2001.</a></li><li><a class="nounderline abstract_t">de Kleer IM, Wedderburn LR, Taams LS, et al. CD4+CD25bright regulatory T cells actively regulate inflammation in the joints of patients with the remitting form of juvenile idiopathic arthritis. J Immunol 2004; 172:6435.</a></li><li><a class="nounderline abstract_t">de Graeff-Meeder ER, van Eden W, Rijkers GT, et al. Juvenile chronic arthritis: T cell reactivity to human HSP60 in patients with a favorable course of arthritis. J Clin Invest 1995; 95:934.</a></li><li><a class="nounderline abstract_t">Prakken AB, van Eden W, Rijkers GT, et al. Autoreactivity to human heat-shock protein 60 predicts disease remission in oligoarticular juvenile rheumatoid arthritis. Arthritis Rheum 1996; 39:1826.</a></li><li><a class="nounderline abstract_t">Kamphuis S, Kuis W, de Jager W, et al. Tolerogenic immune responses to novel T-cell epitopes from heat-shock protein 60 in juvenile idiopathic arthritis. Lancet 2005; 366:50.</a></li><li><a class="nounderline abstract_t">Lehman TJ. Juvenile idiopathic arthritis and HSP60 vaccination: selective down-regulation? Lancet 2005; 366:9.</a></li><li><a class="nounderline abstract_t">Murray KJ, Grom AA, Thompson SD, et al. Contrasting cytokine profiles in the synovium of different forms of juvenile rheumatoid arthritis and juvenile spondyloarthropathy: prominence of interleukin 4 in restricted disease. J Rheumatol 1998; 25:1388.</a></li><li><a class="nounderline abstract_t">Gattorno M, Facchetti P, Ghiotto F, et al. Synovial fluid T cell clones from oligoarticular juvenile arthritis patients display a prevalent Th1/Th0-type pattern of cytokine secretion irrespective of immunophenotype. Clin Exp Immunol 1997; 109:4.</a></li><li><a class="nounderline abstract_t">Hunter PJ, Nistala K, Jina N, et al. Biologic predictors of extension of oligoarticular juvenile idiopathic arthritis as determined from synovial fluid cellular composition and gene expression. Arthritis Rheum 2010; 62:896.</a></li><li><a class="nounderline abstract_t">Julé AM, Hoyt KJ, Wei K, et al. Th1 polarization defines the synovial fluid T cell compartment in oligoarticular juvenile idiopathic arthritis. JCI Insight 2021; 6.</a></li><li><a class="nounderline abstract_t">Patel A, Varsani H, Wederburn LR. The hyporesponsiveness of synovial T cells in juvenile idiopathic arthritis is a property of CD4+CD25+ T cells: evidence for regulatory T cells in juvenile arthritis. Rheumatology (Oxford) 2003; 42:S11 (Abstract).</a></li><li><a class="nounderline abstract_t">Wedderburn LR, Robinson N, Patel A, et al. Selective recruitment of polarized T cells expressing CCR5 and CXCR3 to the inflamed joints of children with juvenile idiopathic arthritis. Arthritis Rheum 2000; 43:765.</a></li><li><a class="nounderline abstract_t">Thompson SD, Luyrink L, Passo MH, et al. Comparison of the beta-chemokine receptors CCR4 and CCR5 expression on T-cells in paired synovial fluid and peripheral blood from juvenile rheumatopid arthritis patients. Arthritis Rheum 1999; 42:S185 (Abstract).</a></li><li><a class="nounderline abstract_t">Thompson SD, Luyrink LK, Graham TB, et al. Chemokine receptor CCR4 on CD4+ T cells in juvenile rheumatoid arthritis synovial fluid defines a subset of cells with increased IL-4:IFN-gamma mRNA ratios. J Immunol 2001; 166:6899.</a></li><li><a class="nounderline abstract_t">Scola MP, Thompson SD, Tsoras M, et al. JRA synovial tissues: Abundance of macrophage products including IL-15 and the chemokines MCP-1, IL-8, and MIP-1alpha. Arthritis Rheum 1999; 42:S394 (Abstract).</a></li><li><a class="nounderline abstract_t">Nistala K, Moncrieffe H, Newton KR, et al. Interleukin-17-producing T cells are enriched in the joints of children with arthritis, but have a reciprocal relationship to regulatory T cell numbers. Arthritis Rheum 2008; 58:875.</a></li><li><a class="nounderline abstract_t">Omoyinmi E, Hamaoui R, Pesenacker A, et al. Th1 and Th17 cell subpopulations are enriched in the peripheral blood of patients with systemic juvenile idiopathic arthritis. Rheumatology (Oxford) 2012; 51:1881.</a></li><li><a class="nounderline abstract_t">Dobloug JH, Førre O, Kvien TK, et al. Natural killer (NK) cell activity of peripheral blood, synovial fluid, and synovial tissue lymphocytes from patients with rheumatoid arthritis and juvenile rheumatoid arthritis. Ann Rheum Dis 1982; 41:490.</a></li><li><a class="nounderline abstract_t">Villanueva J, Lee S, Giannini EH, et al. Natural killer cell dysfunction is a distinguishing feature of systemic onset juvenile rheumatoid arthritis and macrophage activation syndrome. Arthritis Res Ther 2005; 7:R30.</a></li><li><a class="nounderline abstract_t">Martini A, Ravelli A, Notarangelo LD, et al. Enhanced interleukin 1 and depressed interleukin 2 production in juvenile arthritis. J Rheumatol 1986; 13:598.</a></li><li><a class="nounderline abstract_t">de Benedetti F, Massa M, Robbioni P, et al. Correlation of serum interleukin-6 levels with joint involvement and thrombocytosis in systemic juvenile rheumatoid arthritis. Arthritis Rheum 1991; 34:1158.</a></li><li><a class="nounderline abstract_t">Pascual V, Allantaz F, Arce E, et al. Role of interleukin-1 (IL-1) in the pathogenesis of systemic onset juvenile idiopathic arthritis and clinical response to IL-1 blockade. J Exp Med 2005; 201:1479.</a></li><li><a class="nounderline abstract_t">Maeno N, Takei S, Nomura Y, et al. Highly elevated serum levels of interleukin-18 in systemic juvenile idiopathic arthritis but not in other juvenile idiopathic arthritis subtypes or in Kawasaki disease: comment on the article by Kawashima et al. Arthritis Rheum 2002; 46:2539.</a></li><li><a class="nounderline abstract_t">Muzaffer MA, Dayer JM, Feldman BM, et al. Differences in the profiles of circulating levels of soluble tumor necrosis factor receptors and interleukin 1 receptor antagonist reflect the heterogeneity of the subgroups of juvenile rheumatoid arthritis. J Rheumatol 2002; 29:1071.</a></li><li><a class="nounderline abstract_t">Beutler B. TNF, immunity and inflammatory disease: lessons of the past decade. J Investig Med 1995; 43:227.</a></li><li><a class="nounderline abstract_t">Jarvis JN, Jiang K, Frank MB, et al. Gene expression profiling in neutrophils from children with polyarticular juvenile idiopathic arthritis. Arthritis Rheum 2009; 60:1488.</a></li><li><a class="nounderline abstract_t">Frosch M, Vogl T, Seeliger S, et al. Expression of myeloid-related proteins 8 and 14 in systemic-onset juvenile rheumatoid arthritis. Arthritis Rheum 2003; 48:2622.</a></li><li><a class="nounderline abstract_t">Foell D, Wittkowski H, Hammerschmidt I, et al. Monitoring neutrophil activation in juvenile rheumatoid arthritis by S100A12 serum concentrations. Arthritis Rheum 2004; 50:1286.</a></li><li><a class="nounderline abstract_t">Tsokos GC, Mavridis A, Inghirami G, et al. Cellular immunity in patients with systemic juvenile rheumatoid arthritis. Clin Immunol Immunopathol 1987; 42:86.</a></li><li><a class="nounderline abstract_t">Tsokos GC, Inghirami G, Pillemer SR, et al. Immunoregulatory aberrations in patients with polyarticular juvenile rheumatoid arthritis. Clin Immunol Immunopathol 1988; 47:62.</a></li><li><a class="nounderline abstract_t">Morbach H, Wiegering V, Richl P, et al. Activated memory B cells may function as antigen-presenting cells in the joints of children with juvenile idiopathic arthritis. Arthritis Rheum 2011; 63:3458.</a></li><li><a class="nounderline abstract_t">Barnes MG, Grom AA, Thompson SD, et al. Biologic similarities based on age at onset in oligoarticular and polyarticular subtypes of juvenile idiopathic arthritis. Arthritis Rheum 2010; 62:3249.</a></li><li><a class="nounderline abstract_t">Lipnick RN, Tsokos GC. Immune abnormalities in the pathogenesis of juvenile rheumatoid arthritis. Clin Exp Rheumatol 1990; 8:177.</a></li><li><a class="nounderline abstract_t">Cassidy JT, Petty RE, Sullivan DB. Abnormalities in the distribution of serum immunoglobulin concentrations in juvenile rheumatoid arthritis. J Clin Invest 1973; 52:1931.</a></li><li><a class="nounderline abstract_t">Pelkonen P, Savilahti E, Mäkelä AL. Persistent and transient IgA deficiency in juvenile rheumatoid arthritis. Scand J Rheumatol 1983; 12:273.</a></li><li><a class="nounderline abstract_t">Allen JC, Kunkel HG. Hidden rheumatoid factors with specificity for native gamma globulins. Arthritis Rheum 1966; 9:758.</a></li><li><a class="nounderline abstract_t">Moore T, Dorner RW, Zuckner J. Hidden rheumatoid factor in seronegative juvenile rheumatoid arthritis. Ann Rheum Dis 1974; 33:255.</a></li><li><a class="nounderline abstract_t">Moore TL, Zuckner J, Baldassare AR, et al. Complement-fixing hidden rheumatoid factor in juvenile rheumatoid arthritis. Arthritis Rheum 1978; 21:935.</a></li><li><a class="nounderline abstract_t">Schaller JG, Johnson GD, Holborow EJ, et al. The association of antinuclear antibodies with the chronic iridocyclitis of juvenile rheumatoid arthritis (Still's disease). Arthritis Rheum 1974; 17:409.</a></li><li><a class="nounderline abstract_t">Leak AM, Ansell BM, Burman SJ. Antinuclear antibody studies in juvenile chronic arthritis. Arch Dis Child 1986; 61:168.</a></li><li><a class="nounderline abstract_t">Rahi AH, Kanski JJ, Fielder A. Immunoglobulins and antinuclear antibodies in aqueous humour from patients with juvenile "rheumatoid" arthritis (Still's disease). Trans Ophthalmol Soc U K 1977; 97:217.</a></li><li><a class="nounderline abstract_t">Saulsbury FT. Antibody to ribonucleoprotein in pauciarticular juvenile rheumatoid arthritis. J Rheumatol 1988; 15:295.</a></li><li><a class="nounderline abstract_t">Szer W, Sierakowska H, Szer IS. Antinuclear antibody profile in juvenile rheumatoid arthritis. J Rheumatol 1991; 18:401.</a></li><li><a class="nounderline abstract_t">Murray KJ, Szer W, Grom AA, et al. Antibodies to the 45 kDa DEK nuclear antigen in pauciarticular onset juvenile rheumatoid arthritis and iridocyclitis: selective association with MHC gene. J Rheumatol 1997; 24:560.</a></li><li><a class="nounderline abstract_t">Dong X, Wang J, Kabir FN, et al. Autoantibodies to DEK oncoprotein in human inflammatory disease. Arthritis Rheum 2000; 43:85.</a></li><li><a class="nounderline abstract_t">Rosenberg AM, Hunt DW, Petty RE. Antibodies to native and denatured type II collagen in children with rheumatic diseases. J Rheumatol 1984; 11:425.</a></li><li><a class="nounderline abstract_t">Godfrey WA, Lindsley CB, Cuppage FE. Localization of IgM in plasma cells in the iris of a patient with iridocyclitis and juvenile rheumatoid arthritis. Arthritis Rheum 1981; 24:1195.</a></li><li><a class="nounderline abstract_t">Petty RE, Hunt DW, Rollins DF, et al. Immunity to soluble retinal antigen in patients with uveitis accompanying juvenile rheumatoid arthritis. Arthritis Rheum 1987; 30:287.</a></li><li><a class="nounderline abstract_t">Uchiyama RC, Osborn TG, Moore TL. Antibodies to iris and retina detected in sera from patients with juvenile rheumatoid arthritis with iridocyclitis by indirect immunofluorescence studies on human eye tissue. J Rheumatol 1989; 16:1074.</a></li><li><a class="nounderline abstract_t">Borel Y, Morimoto C, Cairns L, et al. Anti-T cell antibody in juvenile rheumatoid arthritis. J Rheumatol 1984; 11:56.</a></li><li><a class="nounderline abstract_t">Strelkauskas AJ, Schauf V, Wilson BS, et al. Isolation and characterization of naturally occurring subclasses of human peripheral blood T cells with regulatory functions. J Immunol 1978; 120:1278.</a></li><li><a class="nounderline abstract_t">Barron KS, Lewis DE, Brewer EJ, et al. Cytotoxic anti-T cell antibodies in children with juvenile rheumatoid arthritis. Arthritis Rheum 1984; 27:1272.</a></li><li><a class="nounderline abstract_t">Rossen RD, Brewer EJ, Person DA, et al. Circulating immune complexes and antinuclear antibodies in juvenile rheumatoid arthritis. Arthritis Rheum 1977; 20:1485.</a></li><li><a class="nounderline abstract_t">Balogh Z, Merétey K, Falus A, Bozsóky S. Serological abnormalities in juvenile chronic arthritis: a review of 46 cases. Ann Rheum Dis 1980; 39:129.</a></li><li><a class="nounderline abstract_t">Moore TL, Sheridan PW, Traycoff RB, et al. Immune complexes in juvenile rheumatoid arthritis: a comparison of four methods. J Rheumatol 1982; 9:395.</a></li><li><a class="nounderline abstract_t">Miller JJ 3rd, Olds LC, Huene DB. Complement activation products and factors influencing phagocyte migration in synovial fluids from children with chronic arthritis. Clin Exp Rheumatol 1986; 4:53.</a></li><li><a class="nounderline abstract_t">Miller JJ 3rd, Hsu YP, Moss R, et al. The immunologic and clinical associations of the split products of C3 in plasma in juvenile rheumatoid arthritis. Arthritis Rheum 1979; 22:502.</a></li><li><a class="nounderline abstract_t">Miller JJ 3rd, Olds LC, Silverman ED, et al. Different patterns of C3 and C4 activation in the varied types of juvenile arthritis. Pediatr Res 1986; 20:1332.</a></li><li><a class="nounderline abstract_t">Mollnes TE, Paus A. Complement activation in synovial fluid and tissue from patients with juvenile rheumatoid arthritis. Arthritis Rheum 1986; 29:1359.</a></li><li><a class="nounderline abstract_t">Frosch M, Roth J. New insights in systemic juvenile idiopathic arthritis--from pathophysiology to treatment. Rheumatology (Oxford) 2008; 47:121.</a></li></ol></div><div id="topicVersionRevision">Topic 6429 Version 24.0</div></div>
<div class="row">
<div class="col-12">
<h4 style="text-align: center;padding: 20px;color: cadetblue;">References</h4>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/6626278" id="rid0" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>1 : The epidemiology of juvenile arthritis in Rochester, Minnesota 1960-1979.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/8702448" id="rid1" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>2 : Juvenile rheumatoid arthritis in Rochester, Minnesota 1960-1993. Is the epidemiology changing?</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/5944408" id="rid2" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>3 : A prognostic study of juvenile rheumatoid arthritis. Analysis of 544 cases.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/3768057" id="rid3" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>4 : Incidence of arthritis in urban Finnish children. A prospective study.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/1437440" id="rid4" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>5 : Epidemiology of juvenile chronic arthritis in southwestern Sweden: a 5-year prospective population study.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/7791175" id="rid5" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>6 : Epidemiology of juvenile rheumatoid arthritis in Manitoba, Canada, 1975-92: cycles in incidence.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/8923378" id="rid6" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>7 : Pediatric rheumatology in the United Kingdom: data from the British Pediatric Rheumatology Group National Diagnostic Register.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/2746600" id="rid7" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>8 : The frequency of juvenile arthritis.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/9588729" id="rid8" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>9 : Estimates of the prevalence of arthritis and selected musculoskeletal disorders in the United States.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/9292786" id="rid9" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>10 : Juvenile rheumatoid arthritis: ethnic differences in diagnostic types.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/9292811" id="rid10" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>11 : Juvenile rheumatoid arthritis in African Americans.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/9141266" id="rid11" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>12 : Clinical analysis of 570 cases with juvenile rheumatoid arthritis: results of a nationwide retrospective survey in Japan.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/1137612" id="rid12" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>13 : Pathogenic implications of age of onset in juvenile rheumatoid arthritis.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/263894" id="rid13" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>14 : Juvenile rheumatoid arthritis: Series 1.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/6710254" id="rid14" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>15 : Juvenile chronic arthritis in black and Indian South African children.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/3170286" id="rid15" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>16 : HLA and altered sex ratios in juvenile rheumatoid arthritis sibships.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/4978557" id="rid16" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>17 : Iridocyclitis in juvenile rheumatoid arthritis.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/318121" id="rid17" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>18 : Clinical patterns of chronic iridocyclitis in children with juvenile rheumatoid arthritis.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/4015722" id="rid18" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>19 : Sex ratio and sibship size in juvenile rheumatoid arthritis kindreds.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/4544652" id="rid19" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>20 : Increased prevalence of W27 in juvenile rheumatoid arthritis.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/1271190" id="rid20" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>21 : Histocompatibility antigens in childhood-onset arthritis.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/3378122" id="rid21" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>22 : Antibodies to influenza A in a cluster of children with juvenile chronic arthritis.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/3619968" id="rid22" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>23 : Seasonal variation in systemic onset juvenile rheumatoid arthritis.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/8859257" id="rid23" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>24 : Seasonal onset of systemic-onset juvenile rheumatoid arthritis.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/4941289" id="rid24" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>25 : Familial aggregation and twin studies in Still's disease. Juvenile chronic polyarthritis.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/6766468" id="rid25" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>26 : Familial rheumatoid arthritis: linkage of HLA to disease susceptibility locus in four families where proband presented with juvenile rheumatoid arthritis.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/9365084" id="rid26" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>27 : Juvenile rheumatoid arthritis in affected sibpairs.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/15188369" id="rid27" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>28 : Juvenile rheumatoid arthritis affected sibpairs: extent of clinical phenotype concordance.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/3872363" id="rid28" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>29 : Sibling pairs affected by chronic arthritis of childhood: evidence for a genetic predisposition.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/6974234" id="rid29" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>30 : Juvenile rheumatoid arthritis in children with diabetes mellitus.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/8077468" id="rid30" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>31 : Prevalence of autoimmune diseases in the family members of patients with pemphigus vulgaris.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/1593606" id="rid31" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>32 : Juvenile rheumatoid arthritis and HLA: report of the Park City III workshop.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/762241" id="rid32" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>33 : Different HLA-D associations in adult and juvenile rheumatoid arthritis.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/1979063" id="rid33" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>34 : A distinct HLA-DRw8 haplotype characterizes patients with juvenile rheumatoid arthritis.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/6967490" id="rid34" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>35 : Early-onset pauciarticular juvenile rheumatoid arthritis associated with human leukocyte antigen-DRw5, iritis, and antinuclear antibody.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/3981519" id="rid35" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>36 : HLA genetics and inherited predisposition to JRA.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/6401993" id="rid36" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>37 : HLA antigens in juvenile arthritis. Genetic basis for the different subtypes.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/6606239" id="rid37" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>38 : Increase of HLA-"DRw6" in patients with juvenile chronic arthritis.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/3489465" id="rid38" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>39 : HLA-DP antigens in patients with pauciarticular juvenile rheumatoid arthritis.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/3492783" id="rid39" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>40 : Increased frequency of HLA-DPw2 in pauciarticular onset juvenile chronic arthritis.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/6984467" id="rid40" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>41 : An association between HLA-A2 and juvenile rheumatoid arthritis in girls.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/1625093" id="rid41" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>42 : Human leukocyte antigen-DRB1*1104 in the chronic iridocyclitis of pauciarticular juvenile rheumatoid arthritis.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/1680192" id="rid42" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>43 : HLA-DQA1*0101 haplotypes and disease outcome in early onset pauciarticular juvenile rheumatoid arthritis.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/8457222" id="rid43" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>44 : HLA class II alleles and heterogeneity of juvenile rheumatoid arthritis. DRB1*0101 may define a novel subset of the disease.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/8436419" id="rid44" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>45 : HLA-DP/DR interaction in early onset pauciarticular juvenile chronic arthritis.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/3488035" id="rid45" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>46 : Genetic susceptibility to early onset pauciarticular juvenile chronic arthritis: a study of HLA and complement markers in 158 British patients.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/2261000" id="rid46" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>47 : HLA antigens in juvenile arthritis. Pauciarticular and polyarticular juvenile arthritis are immunogenetically distinct.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/6610692" id="rid47" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>48 : Specific HLA-DR4-associated histocompatibility molecules characterize patients with seropositive juvenile rheumatoid arthritis.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/26598658" id="rid48" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>49 : HLA-DRB1*11 and variants of the MHC class II locus are strong risk factors for systemic juvenile idiopathic arthritis.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/27927641" id="rid49" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>50 : Genetic architecture distinguishes systemic juvenile idiopathic arthritis from other forms of juvenile idiopathic arthritis: clinical and therapeutic implications.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/2446635" id="rid50" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>51 : The shared epitope hypothesis. An approach to understanding the molecular genetics of susceptibility to rheumatoid arthritis.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/1701997" id="rid51" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>52 : Association of HLA-Dw16 with rheumatoid arthritis in Yakima Indians. Further evidence for the "shared epitope" hypothesis.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/10513798" id="rid52" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>53 : Age-specific effects of juvenile rheumatoid arthritis-associated HLA alleles.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/8882415" id="rid53" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>54 : T-cell receptor BV6S1 null alleles and HLA-DR1 haplotypes in polyarticular outcome juvenile rheumatoid arthritis.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/5074359" id="rid54" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>55 : Arthritis and immunodeficiency.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/7848312" id="rid55" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>56 : A genetic association between juvenile rheumatoid arthritis and a novel interleukin-1 alpha polymorphism.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/10616003" id="rid56" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>57 : Identification of a genetic risk factor for systemic juvenile rheumatoid arthritis in the 5'-flanking region of the TNFalpha gene and HLA genes.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/1347283" id="rid57" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>58 : Polymorphism in a T-cell receptor variable gene is associated with susceptibility to a juvenile rheumatoid arthritis subset.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/9769329" id="rid58" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>59 : The effect of novel polymorphisms in the interleukin-6 (IL-6) gene on IL-6 transcription and plasma IL-6 levels, and an association with systemic-onset juvenile chronic arthritis.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/10366102" id="rid59" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>60 : Polymorphic haplotypes of the interleukin-10 5' flanking region determine variable interleukin-10 transcription and are associated with particular phenotypes of juvenile rheumatoid arthritis.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/9082929" id="rid60" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>61 : Juvenile rheumatoid arthritis-like polyarthritis in chromosome 22q11.2 deletion syndrome (DiGeorge anomalad/velocardiofacial syndrome/conotruncal anomaly face syndrome).</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/8203956" id="rid61" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>62 : Increased frequency of TAP2B in early onset pauciarticular juvenile chronic arthritis.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/8730138" id="rid62" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>63 : Polymorphism in the LMP2 gene influences disease susceptibility and severity in HLA-B27 associated juvenile rheumatoid arthritis.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/11508429" id="rid63" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>64 : A novel 5'-flanking region polymorphism of macrophage migration inhibitory factor is associated with systemic-onset juvenile idiopathic arthritis.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/12355488" id="rid64" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>65 : Mutation screening of the macrophage migration inhibitory factor gene: positive association of a functional polymorphism of macrophage migration inhibitory factor with juvenile idiopathic arthritis.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/12483736" id="rid65" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>66 : Linkage and association studies of single-nucleotide polymorphism-tagged tumor necrosis factor haplotypes in juvenile oligoarthritis.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/15934099" id="rid66" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>67 : Association between the PTPN22 gene and rheumatoid arthritis and juvenile idiopathic arthritis in a UK population: further support that PTPN22 is an autoimmunity gene.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/14611119" id="rid67" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>68 : Non-HLA gene polymorphisms in juvenile rheumatoid arthritis.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/14613283" id="rid68" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>69 : The -174G allele of the interleukin-6 gene confers susceptibility to systemic arthritis in children: a multicenter study using simplex and multiplex juvenile idiopathic arthritis families.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/12115193" id="rid69" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>70 : A gene in the telomeric HLA complex distinct from HLA-A is involved in predisposition to juvenile idiopathic arthritis.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/15457461" id="rid70" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>71 : A genome-wide scan for juvenile rheumatoid arthritis in affected sibpair families provides evidence of linkage.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/22294642" id="rid71" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>72 : Investigation of rheumatoid arthritis susceptibility loci in juvenile idiopathic arthritis confirms high degree of overlap.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/22354554" id="rid72" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>73 : Genome-wide association analysis of juvenile idiopathic arthritis identifies a new susceptibility locus at chromosomal region 3q13.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/23603761" id="rid73" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>74 : Dense genotyping of immune-related disease regions identifies 14 new susceptibility loci for juvenile idiopathic arthritis.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/29426059" id="rid74" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>75 : Brief Report: The Genetic Profile of Rheumatoid Factor-Positive Polyarticular Juvenile Idiopathic Arthritis Resembles That of Adult Rheumatoid Arthritis.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/9496193" id="rid75" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>76 : Pathogenesis of juvenile chronic arthritis: genetic and environmental factors.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/19965974" id="rid76" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>77 : Possible environmental determinants of juvenile idiopathic arthritis.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/1593609" id="rid77" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>78 : The role of infection in chronic arthritis.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/48775" id="rid78" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>79 : Rubella-virus infection in juvenile rheumatoid arthritis.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/1081377" id="rid79" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>80 : Rubella antibody levels in juvenile rheumatoid arthritis.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/6185058" id="rid80" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>81 : Serologic studies on the association of rubella virus infection and juvenile rheumatoid arthritis.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/4047116" id="rid81" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>82 : Persistent rubella virus infection associated with chronic arthritis in children.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/19576941" id="rid82" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>83 : A relapse of systemic type juvenile idiopathic arthritis after a rubella vaccination in a patient during a long-term remission period.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/7955625" id="rid83" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>84 : Infection and molecular mimicry in autoimmune diseases of childhood.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/12384932" id="rid84" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>85 : Proinflammatory responses to self HLA epitopes are triggered by molecular mimicry to Epstein-Barr virus proteins in oligoarticular juvenile idiopathic arthritis.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/1491404" id="rid85" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>86 : Chlamydial associated syndrome of arthritis and eye involvement in young children.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/12794831" id="rid86" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>87 : Frequent infection with a viral pathogen, parvovirus B19, in rheumatic diseases of childhood.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/1466598" id="rid87" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>88 : Aetiological role of bacteria associated with reactive arthritis in pauciarticular juvenile chronic arthritis.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/7693941" id="rid88" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>89 : Responses to gram negative enteric bacterial antigens by synovial T cells from patients with juvenile chronic arthritis: recognition of heat shock protein HSP60.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/26195533" id="rid89" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>90 : Antibiotic Exposure and Juvenile Idiopathic Arthritis: A Case-Control Study.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/25320218" id="rid90" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>91 : Repeated exposure to antibiotics in infancy: a predisposing factor for juvenile idiopathic arthritis or a sign of this group's greater susceptibility to infections?</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/6213027" id="rid91" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>92 : Augmented numbers of HLA-DR-positive T lymphocytes in the synovial fluid and synovial tissue of patients with rheumatoid arthritis and juvenile rheumatoid arthritis: in vivo-activated T lymphocytes are potent stimulators in the mixed lymphocyte reaction.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/8187333" id="rid92" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>93 : Local synthesis of both macrophage and T cell cytokines by synovial fluid cells from children with juvenile rheumatoid arthritis.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/644340" id="rid93" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>94 : Light- and electron-microscopic findings of juvenile rheumatoid arthritis synovium: comparison with normal juvenile synovium.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/644339" id="rid94" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>95 : Light- and electron-microscopic studies of normal juvenile human synovium.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/1953812" id="rid95" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>96 : Role of the endothelium in chronic inflammatory synovitis.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/11315918" id="rid96" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>97 : Expression of angiogenic factors in juvenile rheumatoid arthritis: correlation with revascularization of human synovium engrafted into SCID mice.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/10529148" id="rid97" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>98 : Increased circulating vascular endothelial growth factor is correlated with disease activity in polyarticular juvenile rheumatoid arthritis.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/19369471" id="rid98" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>99 : The hypoxic synovial environment regulates expression of vascular endothelial growth factor and osteopontin in juvenile idiopathic arthritis.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/21685110" id="rid99" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>100 : Synovial membrane immunohistology in early untreated juvenile idiopathic arthritis: differences between clinical subgroups.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/6980416" id="rid100" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>101 : Evidence in support of a self-perpetuating HLA-DR-dependent delayed-type cell reaction in rheumatoid arthritis.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/8970050" id="rid101" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>102 : Immunohistological characteristics of T cell infiltrates in different forms of childhood onset chronic arthritis.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/6605750" id="rid102" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>103 : Phenotypic characterization of synovial tissue cells in situ in different types of synovitis.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/3495523" id="rid103" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>104 : Antigen presentation by adherent cells from human peripheral blood. Correlation between T-cell activation and expression of HLA-DQ and -DR antigens.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/2940038" id="rid104" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>105 : The distribution of dendritic cells in the synovial fluids of patients with arthritis.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/2454634" id="rid105" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>106 : Synovial fluid lymphocytes in different subtypes of juvenile rheumatoid arthritis.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/3726548" id="rid106" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>107 : A distinct endothelial cell recognition system that controls lymphocyte traffic into inflamed synovium.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/7511076" id="rid107" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>108 : Adhesion of peripheral blood lymphocytes of children with arthritis to human umbilical vein endothelial cells.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/8843861" id="rid108" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>109 : Patterns of expression of tumor necrosis factor alpha, tumor necrosis factor beta, and their receptors in synovia of patients with juvenile rheumatoid arthritis and juvenile spondylarthropathy.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/9502767" id="rid109" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>110 : Interleukin 15 is produced by endothelial cells and increases the transendothelial migration of T cells In vitro and in the SCID mouse-human rheumatoid arthritis model In vivo.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/11838858" id="rid110" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>111 : Interferon-gamma:interleukin 4 ratios and associated type 1 cytokine expression in juvenile rheumatoid arthritis synovial tissue.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/11817596" id="rid111" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>112 : Macrophage migration inhibitory factor in patients with juvenile idiopathic arthritis.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/12746913" id="rid112" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>113 : Functional and prognostic relevance of the -173 polymorphism of the macrophage migration inhibitory factor gene in systemic-onset juvenile idiopathic arthritis.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/15146431" id="rid113" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>114 : A functional promoter haplotype of macrophage migration inhibitory factor is linked and associated with juvenile idiopathic arthritis.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/2827591" id="rid114" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>115 : Increased prevalence of late stage T cell activation antigen (VLA-1) in active juvenile chronic arthritis.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/10666778" id="rid115" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>116 : Type 1 and type 2 immune responses in children: their relevance in juvenile arthritis.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/21739422" id="rid116" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>117 : Coexpression of chemokine receptors CCR5, CXCR3, and CCR4 and ligands for P- and E-selectin on T lymphocytes of patients with juvenile idiopathic arthritis.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/2961576" id="rid117" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>118 : CD3+4-8-WT31-(T cell receptor gamma+) cells and other unusual phenotypes are frequently detected among spontaneously interleukin 2-responsive T lymphocytes present in the joint fluid in juvenile rheumatoid arthritis. A clonal analysis.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/6213026" id="rid118" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>119 : Detection of T-lymphocyte subpopulation in the peripheral blood and the synovium of patients with rheumatoid arthritis and juvenile rheumatoid arthritis using monoclonal antibodies.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/21702013" id="rid119" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>120 : Impaired suppression of synovial fluid CD4+CD25- T cells from patients with juvenile idiopathic arthritis by CD4+CD25+ Treg cells.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/1836012" id="rid120" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>121 : Analysis of T cell receptor beta chains in Lewis rats with experimental allergic encephalomyelitis: conserved complementarity determining region 3.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/1387614" id="rid121" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>122 : Limited heterogeneity of T cell receptor variable region gene usage in juvenile rheumatoid arthritis synovial T cells.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/8248215" id="rid122" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>123 : Dominant T-cell-receptor beta chain variable region V beta 14+ clones in juvenile rheumatoid arthritis.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/7562772" id="rid123" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>124 : Patterns of T lymphocyte clonal expansion in HLA-typed patients with juvenile rheumatoid arthritis.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/10323206" id="rid124" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>125 : Molecular fingerprinting reveals non-overlapping T cell oligoclonality between an inflamed site and peripheral blood.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/8228260" id="rid125" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>126 : Clonal predominance of T cell receptors within the CD8+ CD45RO+ subset in normal human subjects.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/9506577" id="rid126" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>127 : Comparative sequence analysis of the human T cell receptor beta chain in juvenile rheumatoid arthritis and juvenile spondylarthropathies: evidence for antigenic selection of T cells in the synovium.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/1825059" id="rid127" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>128 : T cell receptor delta diversity of freshly isolated T lymphocytes in rheumatoid synovitis.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/2148643" id="rid128" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>129 : T gamma delta cells in juvenile rheumatoid arthritis and rheumatoid arthritis. In the juvenile rheumatoid arthritis synovium the T gamma delta cells express activation antigens and are predominantly V delta 1+, and a significant proportion of these patients have elevated percentages of T gamma delta cells.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/1411299" id="rid129" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>130 : TCR gamma/delta+ cell subsets in the synovial membranes of patients with rheumatoid arthritis and juvenile rheumatoid arthritis.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/8428387" id="rid130" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>131 : A high proportion of the V delta 1+ synovial fluid gamma delta T cells in juvenile rheumatoid arthritis patients express the very early activation marker CD69, but carry the high molecular weight isoform of the leucocyte common antigen (CD45RA).</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/1717333" id="rid131" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>132 : Antigen specificity of gamma delta T lymphocytes.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/2148638" id="rid132" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>133 : Synovial cells responding to a 65-kDa mycobacterial heat shock protein have a high proportion of a TcR gamma delta subtype uncommon in peripheral blood.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/1674762" id="rid133" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>134 : Recognition of human 60 kD heat shock protein by mononuclear cells from patients with juvenile chronic arthritis.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/9556353" id="rid134" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>135 : Heat shock proteins and arthritis--new readers start here.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/8101016" id="rid135" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>136 : Rheumatoid inflammatory T-cell clones express mostly Th1 but also Th2 and mixed (Th0-like) cytokine patterns.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/12847694" id="rid136" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>137 : The spontaneous remission of juvenile idiopathic arthritis is characterized by CD30+ T cells directed to human heat-shock protein 60 capable of producing the regulatory cytokine interleukin-10.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/15128835" id="rid137" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>138 : CD4+CD25bright regulatory T cells actively regulate inflammation in the joints of patients with the remitting form of juvenile idiopathic arthritis.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/7883993" id="rid138" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>139 : Juvenile chronic arthritis: T cell reactivity to human HSP60 in patients with a favorable course of arthritis.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/8912504" id="rid139" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>140 : Autoreactivity to human heat-shock protein 60 predicts disease remission in oligoarticular juvenile rheumatoid arthritis.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/15993233" id="rid140" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>141 : Tolerogenic immune responses to novel T-cell epitopes from heat-shock protein 60 in juvenile idiopathic arthritis.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/15993212" id="rid141" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>142 : Juvenile idiopathic arthritis and HSP60 vaccination: selective down-regulation?</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/9676774" id="rid142" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>143 : Contrasting cytokine profiles in the synovium of different forms of juvenile rheumatoid arthritis and juvenile spondyloarthropathy: prominence of interleukin 4 in restricted disease.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/9218817" id="rid143" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>144 : Synovial fluid T cell clones from oligoarticular juvenile arthritis patients display a prevalent Th1/Th0-type pattern of cytokine secretion irrespective of immunophenotype.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/20127724" id="rid144" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>145 : Biologic predictors of extension of oligoarticular juvenile idiopathic arthritis as determined from synovial fluid cellular composition and gene expression.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/34403374" id="rid145" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>146 : Th1 polarization defines the synovial fluid T cell compartment in oligoarticular juvenile idiopathic arthritis.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/" id="rid146" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>147 : The hyporesponsiveness of synovial T cells in juvenile idiopathic arthritis is a property of CD4+CD25+ T cells: evidence for regulatory T cells in juvenile arthritis</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/10765921" id="rid147" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>148 : Selective recruitment of polarized T cells expressing CCR5 and CXCR3 to the inflamed joints of children with juvenile idiopathic arthritis.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/" id="rid148" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>149 : Comparison of the beta-chemokine receptors CCR4 and CCR5 expression on T-cells in paired synovial fluid and peripheral blood from juvenile rheumatopid arthritis patients</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/11359851" id="rid149" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>150 : Chemokine receptor CCR4 on CD4+ T cells in juvenile rheumatoid arthritis synovial fluid defines a subset of cells with increased IL-4:IFN-gamma mRNA ratios.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/" id="rid150" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>151 : JRA synovial tissues: Abundance of macrophage products including IL-15 and the chemokines MCP-1, IL-8, and MIP-1alpha</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/18311821" id="rid151" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>152 : Interleukin-17-producing T cells are enriched in the joints of children with arthritis, but have a reciprocal relationship to regulatory T cell numbers.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/22772320" id="rid152" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>153 : Th1 and Th17 cell subpopulations are enriched in the peripheral blood of patients with systemic juvenile idiopathic arthritis.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/6181746" id="rid153" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>154 : Natural killer (NK) cell activity of peripheral blood, synovial fluid, and synovial tissue lymphocytes from patients with rheumatoid arthritis and juvenile rheumatoid arthritis.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/15642140" id="rid154" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>155 : Natural killer cell dysfunction is a distinguishing feature of systemic onset juvenile rheumatoid arthritis and macrophage activation syndrome.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/3090248" id="rid155" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>156 : Enhanced interleukin 1 and depressed interleukin 2 production in juvenile arthritis.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/1930333" id="rid156" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>157 : Correlation of serum interleukin-6 levels with joint involvement and thrombocytosis in systemic juvenile rheumatoid arthritis.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/15851489" id="rid157" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>158 : Role of interleukin-1 (IL-1) in the pathogenesis of systemic onset juvenile idiopathic arthritis and clinical response to IL-1 blockade.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/12355506" id="rid158" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>159 : Highly elevated serum levels of interleukin-18 in systemic juvenile idiopathic arthritis but not in other juvenile idiopathic arthritis subtypes or in Kawasaki disease: comment on the article by Kawashima et al.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/12022325" id="rid159" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>160 : Differences in the profiles of circulating levels of soluble tumor necrosis factor receptors and interleukin 1 receptor antagonist reflect the heterogeneity of the subgroups of juvenile rheumatoid arthritis.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/7614068" id="rid160" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>161 : TNF, immunity and inflammatory disease: lessons of the past decade.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/19404961" id="rid161" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>162 : Gene expression profiling in neutrophils from children with polyarticular juvenile idiopathic arthritis.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/13130482" id="rid162" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>163 : Expression of myeloid-related proteins 8 and 14 in systemic-onset juvenile rheumatoid arthritis.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/15077313" id="rid163" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>164 : Monitoring neutrophil activation in juvenile rheumatoid arthritis by S100A12 serum concentrations.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/3539432" id="rid164" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>165 : Cellular immunity in patients with systemic juvenile rheumatoid arthritis.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/2832112" id="rid165" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>166 : Immunoregulatory aberrations in patients with polyarticular juvenile rheumatoid arthritis.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/21792842" id="rid166" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>167 : Activated memory B cells may function as antigen-presenting cells in the joints of children with juvenile idiopathic arthritis.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/20662067" id="rid167" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>168 : Biologic similarities based on age at onset in oligoarticular and polyarticular subtypes of juvenile idiopathic arthritis.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/2186885" id="rid168" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>169 : Immune abnormalities in the pathogenesis of juvenile rheumatoid arthritis.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/4578296" id="rid169" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>170 : Abnormalities in the distribution of serum immunoglobulin concentrations in juvenile rheumatoid arthritis.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/6623018" id="rid170" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>171 : Persistent and transient IgA deficiency in juvenile rheumatoid arthritis.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/4162823" id="rid171" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>172 : Hidden rheumatoid factors with specificity for native gamma globulins.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/4546351" id="rid172" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>173 : Hidden rheumatoid factor in seronegative juvenile rheumatoid arthritis.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/737017" id="rid173" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>174 : Complement-fixing hidden rheumatoid factor in juvenile rheumatoid arthritis.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/4546940" id="rid174" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>175 : The association of antinuclear antibodies with the chronic iridocyclitis of juvenile rheumatoid arthritis (Still's disease).</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/3485405" id="rid175" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>176 : Antinuclear antibody studies in juvenile chronic arthritis.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/304264" id="rid176" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>177 : Immunoglobulins and antinuclear antibodies in aqueous humour from patients with juvenile "rheumatoid" arthritis (Still's disease).</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/3258919" id="rid177" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>178 : Antibody to ribonucleoprotein in pauciarticular juvenile rheumatoid arthritis.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/1856809" id="rid178" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>179 : Antinuclear antibody profile in juvenile rheumatoid arthritis.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/9058666" id="rid179" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>180 : Antibodies to the 45 kDa DEK nuclear antigen in pauciarticular onset juvenile rheumatoid arthritis and iridocyclitis: selective association with MHC gene.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/10643703" id="rid180" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>181 : Autoantibodies to DEK oncoprotein in human inflammatory disease.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/6332907" id="rid181" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>182 : Antibodies to native and denatured type II collagen in children with rheumatic diseases.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/7030352" id="rid182" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>183 : Localization of IgM in plasma cells in the iris of a patient with iridocyclitis and juvenile rheumatoid arthritis.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/3494455" id="rid183" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>184 : Immunity to soluble retinal antigen in patients with uveitis accompanying juvenile rheumatoid arthritis.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/2685294" id="rid184" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>185 : Antibodies to iris and retina detected in sera from patients with juvenile rheumatoid arthritis with iridocyclitis by indirect immunofluorescence studies on human eye tissue.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/6366227" id="rid185" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>186 : Anti-T cell antibody in juvenile rheumatoid arthritis.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/147907" id="rid186" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>187 : Isolation and characterization of naturally occurring subclasses of human peripheral blood T cells with regulatory functions.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/6437413" id="rid187" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>188 : Cytotoxic anti-T cell antibodies in children with juvenile rheumatoid arthritis.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/303520" id="rid188" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>189 : Circulating immune complexes and antinuclear antibodies in juvenile rheumatoid arthritis.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/6966908" id="rid189" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>190 : Serological abnormalities in juvenile chronic arthritis: a review of 46 cases.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/7120235" id="rid190" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>191 : Immune complexes in juvenile rheumatoid arthritis: a comparison of four methods.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/3486076" id="rid191" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>192 : Complement activation products and factors influencing phagocyte migration in synovial fluids from children with chronic arthritis.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/312646" id="rid192" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>193 : The immunologic and clinical associations of the split products of C3 in plasma in juvenile rheumatoid arthritis.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/3099253" id="rid193" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>194 : Different patterns of C3 and C4 activation in the varied types of juvenile arthritis.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/3778542" id="rid194" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>195 : Complement activation in synovial fluid and tissue from patients with juvenile rheumatoid arthritis.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/17971384" id="rid195" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>196 : New insights in systemic juvenile idiopathic arthritis--from pathophysiology to treatment.</p>
</a>
</div>
</div>
</div>
</div>

</section>

</section>
<!-- End Main Menu Area -->
<!-- Start Search Popup Area -->


<!-- End Footer Area -->
<!-- Back to top -->

<a class="scrolltop" href="#top"><i class="icofont-hand-drawn-up"></i></a>
<!-- End Back to top -->
<!-- jQuery Min JS -->

<!-- Prpper JS -->

<!-- Bootstrap Min JS -->

<!-- Classy Nav Min Js -->

<!-- Owl Carousel Min Js -->

<!-- Magnific Popup JS -->

<!-- CounterUp JS -->

<!-- Waypoints JS -->

<!-- Form Validator Min JS -->

<!-- Contact Form Min JS -->

<!-- Main JS -->

<!-- Global site tag (gtag.js) - Google Analytics -->






</body>
</html>
